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Zusammenfassung 
 
Das Herz ist ein Muskel, der das Blut durch den Körper pumpt um die Zellen mit 
Sauerstoff und Nährstoffen zu versorgen. Diese Pumpfunktion wird durch zwei 
besondere Charakteristiken der Herzzellen ermöglicht: (i) elektrische Erregbarkeit und 
(ii) Kontraktilität. Das Aktionspotenzial (AP) der Kardiomyozyten wird durch eine Welle 
von koordiniertem Öffnen und Schließen verschiedener Ionenkanäle geformt. Das 
Öffnen kardialer Ca2+-Kanäle induziert einen Ca2+-Einstrom, der zu einer massiven Ca2+ 
Ausschüttung aus dem Sarkoplasmatischen Retikulum führt. Der weit verbreitete, 
sekundäre Botenstoff Kalzium stellt hierbei die Verbindung zwischen der elektrischen 
Erregung und der mechanischen Kontraktion her, im folgenden elektro-mechanische  
Kopplung (EMK) genannt. Eine große Vielfalt intrazellulärer Signalkaskaden regulieren 
die physiologischen Eigenschaften von Kardiomyozyten. In dieser Arbeit habe ich 
solche Signalkaskaden und deren regulatorischen Prozesse untersucht, um deren 
Einfluss auf die Physiologie und Pathophysiologie des Herzen zu quantifizieren. Dabei 
konzentrierte ich mich auf  die folgenden Fragestellungen: (i) Modulieren  Gαq/11–
gekoppelte Signalwege die elektrophysiologischen Eigenschaften von ventrikulären 
Myozyten aus dem Mäuseherz? (ii) Sind Gαq/11–gekoppelte Signalwege an durch 
Hyperaldosteronismus (HA) induzierten Veränderungen der elektrophysiologischen 
Eigenschaften von Maus-Kardiomyozyten beteiligt? (iii) Welche Wirkung hat die 
Veränderung der Calmodulin-Bindung von Cav1.2 auf die EMK? iv) Hat die GTPase 
Rac1 einen Einfluss auf die EMK?	  v) Kann Cytochalasin D die elektrophysiologischen 
Eigenschaften von ventrikulären Myozyten aus der Ratte in Langzeitkulturen 
konservieren? 
Gαq/11 gekoppelte Rezeptoren werden in vivo durch Hormone wie Endothelin-1, 
Angiotensin-II und Epinephrine stimuliert. Durch akute Stimulation kommt es unter 
anderem zu einem Anstieg der intrazellulären Ca2+ Konzentration und in Folge dessen 
zu einer Aktivierung Ca2+-abhängiger Proteine wie z.B. die konventionelle Protein 
Kinase C oder Calmodulin. Beides, direkter Kalziumanstieg wie auch Aktivierung 
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Kalzium-abhängiger Prozesse, moduliert die kontraktile Antwort der Kardiomyozyten. 
Demgegenüber führt eine chronische Stimulation von Gαq/11 Signalkaskaden zu 
pathologischen Antworten, z.B. Herzrhythmusstörungen, Hypertrophie oder 
Herzversagen. Trotz zahlreicher Untersuchungen der pathologischen Rolle von Gαq/11 
gekoppelten Signalwegen, ist über deren physiologische Funktion in Kardiomyozyten 
wenig bekannt. In dieser Arbeit habe ich die Effekte der Deaktivierung der Gene gnaq 
und/oder gna11 auf die elektrophysiologischen Eigenschaften ventrikulärer Myozyten 
untersucht und dabei Veränderungen der Membrankapazität, dem 
Ruhemembranpotenzial und der Aktionspotenzial (AP) Amplitude gefunden. Die Dauer 
des AP blieb hierbei unverändert. Daraus schloss ich, dass eine niedrige 
(physiologische) Stimulation sowohl von Gαq- wie auch Gα11–gekoppelten Signalwegen 
von großer Bedeutung für die grundsätzlichen Eigenschaften der Kardiomyozyten wie 
z.B. deren elektrophysiologischen Eigenschaften sind.   
Das natürliche Hormon Aldosteron beeinflusst das Blutvolumen und damit den 
Blutdruck. Neben diesen hämodynamischen Effekten führt ein Überschuss von 
Aldosteron (Hyperaldosteronismus, HA) beim Menschen zu Erkrankungen des 
gesamten Organismus wie z.B. Hypertronie. Chronische Hypertronie wiederum führt zu 
Herzerkrankungen. Vor kurzem wurde interessanterweise berichtet, dass HA auch 
unabhängig vom Blutdruck zu Hyperthrophie und Herzversagen führen kann. Der genau 
Mechanismus hierbei und besonders dessen Signalkaskade in Kardiomyozyten ist 
jedoch weitestgehend unbekannt. Ich habe in dieser Arbeit die Effekte von HA auf die 
elektrophysiologischen Eigenschaften von Kardiomyozyten untersucht und dabei eine 
wesentliche Abnahme der Dauer des AP sowie eine Erhöhung des transienten 
Auswärtsstroms, Itoc, festgestellt. Weiterhin konnte ich durch Induzierung einer HA in 
Gαq/Gα11 Doppelknockout Mäusen eine mögliche Beteiligung der Gαq/11-gekoppelten 
Signalwege bei den HA-induzierten Veränderungen der elektrophysiologischen 
Eigenschaften der Kardiomyozyten nachweisen. Daraus folgerte ich, dass HA zu einer 
zellulären elektrophysiologischen Remodellierung beiträgt, und dass dieser Effekt durch 
Zielproteine innerhalb von Gαq/11–gekoppelten Signalwegen gesteuert wird. 
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Die Eigenschaften des kardialen Ca2+ Kanals Cav1.2 werden durch verschiedene 
Mechanismen reguliert, wie etwa der Ca2+- und spannungsabhängigen Inaktivierung. 
Das Ca2+ bindende Protein Calmodulin (CaM) vermittelt hierbei die Ca2+-abhängige 
Inaktivierung (CDI). Ca2+ gesättigtes CaM interagiert mit dem sogenannten IQ Motiv im 
C-Terminus des Cav1.2-Proteins, um die Kalzium-abhängige Inaktivierung zu 
induzieren. Zur weiteren Untersuchung der Effekte der IQ-CaM Interaktion in der 
Cav1.2 Regulation wurde eine I/E Mutation (Ile1624 zu Glu) in der IQ Sequenz 
generiert. In dieser Arbeit habe ich die Effekte einer I/E Mutation des IQ Motivs auf die 
(i) Cav1.2 Funktion (ii) und die EMK untersucht. Dabei zeigte sich interessanterweise, 
dass die I/E Mutation eine wesentliche Reduzierung der ICa,L Dichte verursacht. Trotz 
dieser niedrigen Dichte war die Amplitude von globalen Ca2+ Transienten in den 
ventrikulären Zellen der I/E Mäuse gesteigert. Ich konnte aufzeigen, dass diesem 
Phänomen eine Zunahme der Verstärkungsfunktion in der EMK zugrund lag. Diese 
übersteigerte Verstärkung des Kalziumeinstroms in der EMK war letztendlich die 
Ursache für kardiale Dysfunktion  in den Mäusen mit der I/E Mutation.  
Rac1 ist ein monomeres G-Protein, das durch einen Integrin-gekoppelten Signalweg 
aktiviert werden kann. Es stimuliert verschiedene zelluläre Prozesse, wie z.B. die 
Organisation des Zytoskeletts und die Produktion von reaktiven Sauerstoffradikalen 
(ROS). Bei einer Vielzahl von kardialen Pathologien, wie Kardiomyopathien und 
Herzrhythmusstörungen, kommt es zu einer Aktivitäts- und Expressionssteigerung von 
Rac1. Dennoch sind die hierbei auftretenden zellulären Mechanismen weitestgehend 
unerforscht. In dieser Arbeit habe ich die Effekte der Expression eines konstitutiv 
aktiven Rac1 (V12Rac1), in sogenannten RacET Mäusen, auf die EMK in ventrikulären 
Myozyten untersucht. Trotz einer erheblichen Abnahme des ICa,L, war die Amplitude der 
global Ca2+ Transienten in den ventrikulären Zellen von RacET Mäuse erhöht. Ähnlich 
wie bei den I/E-Mäusen liegt dieser Amplitudensteigerung eine erhöhte 
Verstärkungsfunktion in der EMK zugrunde.  
Die Möglichkeit der Kultivierung von Kardiomyozyten ist deswegen von so Bedeutung, 
weil isolierte adulte Kardiomyozyten innerhalb weniger Stunden einem Remodellierung 
Prozess unterliegen, der zu einer De-Differenzierung der Herzmuskelzellen führt. Für 
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viele experimentelle Ansätze, wie z.B. chronische Hormongaben in vitro oder 
heterologe Expression von Proteinen, wäre eine Kultivierungskmöglichkeit von 
mehreren Tagen ohne De-Differenzierung der Zellen von großem Vorteil. Deswegen 
haben sich in der Forschung verschiedene Methoden etabliert, die versucht haben die 
Zellkulturkonditionen verbessern. Cytochalasin D (CytoD), ein Pilzmetabolit, ist bekannt 
für seine positiven Effekte auf die Kardiomyozytenkultivierung, da es deren Morphologie 
konserviert. Ich habe in dieser Arbeit zudem untersucht, ob CytoD auch die Funktion 
der Kardiomyozyten erhalten kann. Bei den Untersuchungen des AP konnte ich 
feststellen, dass 0.5 µM CytoD die elektrophysiologischen Eigenschaften adulte 
ventrikulärer Myozyten der Ratte über eine Dauer von 3 Tagen in der Kultur 
konservieren kann. Der Einsatz von CytoD bei der routinemäßigen Kultivierung von 
Kardiomyozyten ist folglich dann empfehlenswert, wenn es darum geht sowohl die 
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Summary  
 
The heart is a muscular organ that pumps the blood throughout the entire body, 
supplying the cells with O2 and nutrients. The pumping property originates from two 
important inherent characteristics of cardiac cells: excitability and contractility. 
Cardiomyocyte’s action potential (AP) comprises a wave of coordinated openings and 
closings of multiple ion channels. The opening of cardiac Ca2+ channels results in Ca2+ 
influx that triggers a much larger Ca2+ release from sarcoplasmic reticulum, which is 
required for contraction. Therefore, the ubiquitous second-messenger Ca2+ links the 
electrical excitation to the mechanical contraction, a process called excitation-
contraction (EC) coupling. Various intracellular signaling cascades regulate the 
physiological properties of cardiomyocytes including excitability and contractility. In this 
thesis, I studied these signaling pathways and regulatory processes and their 
contribution into the physiology and pathophysiology of cardiac cells. In particular, I 
addressed the following questions: (i) do Gαq/11 signaling pathways modulate the 
electrophysiological properties of mouse ventricular myocytes? (ii) are Gαq/11 pathways 
involved in hyperaldosteronism (HA)-induced alterations of cardiomyocytes’ 
electrophysiological properties? (iii) what is the effect of altering calmodulin-binding of 
Cav1.2 on EC coupling gain? (iv) does the small GTPase Rac1 influence the EC 
coupling gain? (v) can Cytochalasin D preserve the electrophysiological properties of rat 
ventricular myocytes in long-term culture? 
Gαq/11 signaling is activated following binding of hormones such as endothelin-1, 
angiotensin-II or epinephrine to G-protein coupled receptors. Acute activation of these 
signaling pathways lead to non-genomic responses such as an increase in intracellular 
Ca2+ levels and activation of various PKC isoforms which both modulate 
cardiomyocyte’s contractility. In contrast, chronic stimulation of Gαq/11 signaling 
pathways results in pathological responses such as hypertrophy and heart failure, so 
called genomic effects. In cardiomyocytes, despite the increasing number of 
investigations on the pathological effects of Gαq/11 signaling, its physiological function is 
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not well understood. In this thesis I studied the effects of Gαq/Gα11-protein knockout on 
the electrophysiological characteristics of mouse ventricular myocytes and found 
alterations of membrane capacitance, resting membrane potential and AP amplitude, 
but not AP duration. Therefore, I concluded that both Gαq and Gα11 are instrumental to 
the electrophysiological properties of cardiomyocytes by mediating the continuance of a 
basic rate of gene expression. 
Aldosterone is a hormone that causes water retention in the kidney and consequently 
increases the blood volume and thus helps to maintain the blood pressure. Besides its 
homeostatic effect, aldosterone excess leads to pathological responses; one of the best 
known is hypertension. Persistent hypertension in turn results in various cardiac 
diseases. Previously, aldosterone was proposed to induce cardiac pathological 
responses independent of its effects on blood pressure. However the mechanism of 
aldosterone function and especially the signaling cascades involved in the responses of 
the cells, have not been well understood. In this thesis, I investigated the effects of HA 
on the cardiomyocyte’s electrophysiology and found a substantial reduction of AP 
duration and Itoc up-regulation. Moreover, by inducing HA in Gαq/Gα11 knockout mice I 
found a possible contribution of Gαq/11 signaling in the aldosterone-induced alteration of 
cardiomyocyte’s electrophysiology. Thus, I concluded that aldosterone induces 
remodeling of cellular electrophysiology and Gαq/11 signaling cascades are essentially 
involved in these genomic responses. 
Following voltage-dependent activation, Cav1.2-channels can undergo voltage and/or 
Ca2+-dependent inactivation. The Ca2+-binding protein calmodulin (CaM) mediates the 
latter inactivation (CDI). Ca2+-saturated CaM interacts with the IQ motif in the C 
terminus of Cav1.2 to accomplish this. To further investigate the impact of IQ-CaM 
interaction in Cav1.2 regulation, I/E mutation (Ile1624 to Glu) was generated in IQ 
sequence. Here I studied the effects of I/E mutation of IQ motif on the (i) Cav1.2 
function and (ii) EC coupling gain. Interestingly, I/E mutation caused a substantial 
decrease of ICa,L density. Despite ICa,L reduction, the amplitude of global Ca2+ transients 
were increased in the ventricular myocytes from I/E mice, as a result of an enhanced 
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EC coupling gain. This increase in intracellular Ca2+ levels due to higher EC coupling 
gain was ultimately the cause of cardiac dysfunction in mice with the I/E mutation. 
Rac1 is a monomeric G-protein that is activated downstream to integrin signaling and 
stimulates various cellular processes including cytoskeletal reorganization and ROS 
production. Rac1 has been shown to contribute to the development of cardiac 
pathological responses such as cardiomyopathy and atrial fibrillations. However the 
underlying mechanisms are not well understood. In this thesis, I studied the effects of 
expression of a constitutively active Rac1 (V12Rac1) on the EC coupling gain in 
ventricular myocytes. Despite a substantial decrease in steady-state ICa,L, the amplitude 
of global Ca2+ transients were increased in ventricular myocytes expressing 
constitutively active Rac1, as a result of an enhanced EC coupling gain. The higher 
intracellular Ca2+ levels, similar to I/E mutation, were the primary cause of cardiac 
dysfunction. 
The potential to culture cardiomyocytes is highly important due to the fact that isolated 
adult cardiomyocytes initiate the process of remodeling in a few hours which leads to 
de-differentiation of cardiac cells. However, some biological studies such as chronic 
hormone treatment in vitro or expression of exogenous proteins by adenoviral gene 
transfer needs culturing of cardiomyoctes for longer time periods even days. Therefore 
different approaches were employed to prevent this remodeling process. Cytochalasin 
D (CytoD), a fungi metabolite, has been reported to have beneficial effect in the culture 
of cardiac cells since it could preserve the cardiomyocyte’s morphology. In this thesis I 
investigated whether CytoD can preserve the cardiomyocyte’s function, too. Studying 
the action potential, I found that CytoD at 0.5 µM can preserve the electrophysiological 
properties of ventricular myocytes along with morphology over a culturing period of 
three days. Thus, CytoD (0.5 µM) can be used as a routine culture supplement in 
primary culture of cardiomyocytes to preserve both morphology and function. 
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1. Introduction  
1.1. The heart anatomy 
The heart is a muscular organ, which pumps the blood throughout the entire body. The 
blood provides O2 and nutrients and removes excretory products in the vicinity of every 
single cell, thus ensures the cell survival. The pumping property originates from the 
intrinsic characteristics of the heart muscle. This muscle builds the walls of 4 heart 
chambers: right and left atria, right and left ventricles. The right atrium is separated from 
the right ventricle by the tricuspid valve whereas the left chambers (the left atrium and 




Figure 2.1: The graphical illustration of the anatomy of the heart. The heart chambers and valves as well as the 
blood circulation in the heart are shown. For detailed explanation see 1.1. Image taken from www.en.wikibooks.org 
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The atria have a thin wall and develop relatively low pressure. While the thicker 
muscular walls of the ventricles provide enough force for pumping of the blood to the 
arteries. A wave of contraction, which starts in the atria (atrial systole) and continues in 
the ventricles (ventricular systole), generate a heartbeat. Each heartbeat results in the 
ejection of blood to the arteries. The percentage of blood volume that is pumped out of 
a filled ventricle with each heartbeat, is called ejection fraction (EF) 65. The beating 
frequency and EF are normally regulated in response to the body needs. For instance 
both heart rate and ventricular ejection are enhanced during exercise. After the 
contraction phase, all four chambers are relaxed (diastole). 
 
1.2. The conduction system of the heart 
In the previous section, the heartbeat was introduced as the driving force for blood 
ejection. But what is the trigger for the heartbeat? Does the cardiac muscle contract 
spontaneously or does it need a stimulus? The regular sequence of contraction of heart 
muscle contraction shows the necessity for a stimulus. The initial trigger for the 
heartbeat appears to be the electrical impulses, which originate from a group of 
specialized myocardial cells called the sinoatrial (SA) node. The electrical impulses 
initiated in the SA node propagate through the entire atrial muscle via the intermodal 
atrial pathways. After a delay in the atrioventricular (AV) node, the electrical excitation 
enters the ventricles via the bundle of His. The bundle of His has two branches: right 
and left bundle branches that enter the right and left ventricles, respectively. The wave 
of depolarization propagates into the ventricular muscle via the Purkinje fibers. The 
Purkinje network ensures the synchronized activation of both ventricles. Thus, the 





gnaq gna11 Cre status Tamoxifen 
Gqfl G11wt Cre- Tam+ 
flox/flox wt/wt 0/0 + 
Gqfl G11wt Cre+ Tam+ 
flox/flox wt/wt tg/0 + 
flox/flox -/- 0/0 + 
flox/flox -/- tg/0 + 
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Figure 1.2: The graphical illustration of the heart conduction system. For detailed explanation see 1.2. Image taken 
from www.scienceart.com  
 
1.3. Structure of a working cardiomyocyte  
The cardiomyocytes are the working units of the heart. They have two important 
functional properties: (i) excitability and (ii) contractility. Both properties originate from 
their specialized structures.  
The plasma membrane of the cardiomyocyte contains numerous ion channels and 
transporters that mediate ion influx and efflux and lead to the various ionic distribution 
across the membrane. These ionic movements are the basis for the cardiomyocytes’ 
excitability, which will be explained in 1.4.  
The other feature of the cardiomyocyte, are the invaginations of the plasma membrane 
that create the transverse tubular (t-tubular) system (Figure 1.3). This system is formed 
and stabilized by the cytoskeleton 108 and ensures the rapid and synchronous 
contraction of the cardiomyocyte 31. Similar to the surface membrane, t-tubules contain 
different ion channels and transporters that facilitate the propagation of the electrical 
impulse into the cell interior. This process leads to the activation of a large number of 
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Ca2+ channels in the t-tubules 99. The resulting Ca2+ influx is the main trigger for the 
increase in the intracellular Ca2+ concentration ([Ca2+]i), which is the primary 
requirement for the activation of contraction. The sarcoplasmic reticulum (SR) is the 
main Ca2+ store of the cell and SR Ca2+ release is triggered by the Ca2+ influx across 
the membrane. As a result of the t-tubular system, the plasma membrane is located in 
the close proximity of the SR membrane, building the dyadic space that is about 15 nm 
wide 156 to facilitate the Ca2+ induced Ca2+ release from the SR. Therefore, the t-tubules 
play an important role in the coupling of electrical excitation to the contraction, a 
phenomena called excitation-contraction (EC) coupling. A large number of cardiac 
diseases such as heart failure are associated with t-tubular disarray 207. 
 
	  
Figure 1.3: 	  Schematic representation of cardiomyocyte’s subcellular architecture. T-tubules are the invaginations of 
plasma membrane that proximate sarcolemmal Cav1.2 channels to SR Ca2+ release channels on the sarcoplasmic 
reticulum. The contractile filaments that are structured as sarcomeres are responsible for contractility in response to 
Ca2+release from the sarcoplasmic reticulum. Taken from Smyth and Shaw, 2010 180. 
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In addition to the specialized features of the cell membrane, the cardiac myocyte 
contains thick (or myosin) and thin (or actin) filaments as well as associated contractile 
and skeletal components, which together build the contractile machinery of the cell. The 
special alignment of contractile filaments results in a cross-striated pattern in the cardiac 
cells (Figure 1.3). The remaining volume of cardiomyocyte is mostly occupied by the 















	   6	  
1.4. The electrophysiological properties of a cardiomyocyte  
1.4.1. Resting membrane potential (VR)  
The membrane potential results from different distributions (Table 1.1) and 
conductances of ions across the membrane. 
 
Table 4.1: Different distributions of Na+, K+, Ca2+ and Cl- across the membrane and their Nernst potential 23.   
Ion (x)	   [x]o (mM)	   [x]i (mM)	   Ex (mV)	  
Na+	   135-145	   10	   +70	  
K+	   3.5-5	   155	   -89	  
Ca2+	   2	   10-4	   +125	  
Cl-	   95-110	   10-20	   -55	  
 
In cardiomyocytes, the plasma membrane is preferentially permeable to K+ and the 
resting potential is mainly determined by the equilibrium potential of this ion. The 
equilibrium potential is the potential at which the chemical gradient of an ion is balanced 
by the electrical gradient across the membrane (net current flow=0) and can be 




  ln  ! ! !
! ! !
                      Nernst equation 
Where Em is the membrane potential, R the gas constant, T the absolute temperature, Z 
the valence of the ion, F the Faraday constant, P the permeability to the ion, [x]o and [x]i 
extracellular and intracellular ion concentrations, respectively. 
Despite the lower permeability of the membrane to other ions such as Na+ and Ca2+, 
they also contribute to the resting membrane potential (VR). The resulting potential 













)            GHK Equation  
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How are the resting concentration gradients of Na+ and K+ maintained across the 
membrane? The Na+/K+-ATPase consumes one ATP to actively transport 3 Na+ out of 
and 2 K+ into the cell, which maintains the electrochemical gradients for Na+ and K+, 
thus contributes to the VR. 
 
1.4.2. Action potential (AP) 
The cardiac action potential (AP) comprises a wave of finely tuned coordinated 
openings and closings of multiple ion channels 181. Voltage-gated ion channels e.g. Na+, 
K+, and Ca2+ channels contribute to the cardiac AP in a particular way. The shape and 
duration of the cardiac APs vary greatly among different regions of the heart (Figure 
1.4) as well as specific areas within those regions (epicardium vs. endocardium) 17.  
 
	  
Figure 1.4: APs in different regions of the heart. The schematic illustration of different shapes and durations of APs in 
atria, ventricle and heart conduction system. The temporal sequence of AP propagation throughout the heart is 
reflected in the figure. Taken from Barry & Nerbonne, 1996 17. 
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Figure 1.5: Cardiac AP and the major underlying ion currents. Different phases of cardiac AP (A) and the contribution 
of each current for shaping every phase (B), are displayed. The amplitudes of the depolarizing (downward) and 
repolarizing (upward) currents are not on the same scales. For abbreviations: see text. Modified from Snyders, 1999 
181. 
 
Figure. 1.5 illustrates a human ventricular AP and its underlying currents. As shown, the 
ventricular AP can be subdivided into 5 different phases. The initial upstroke (phase 0) 
results from the activation of the fast inward Na+ current (INa). The transient rapid 
repolarization (phase 1) is a result of the activation of transient outward K+ current (Ito1) 
and ultrarapid delayed rectifier K+ current (IKur) along with the rapid voltage-dependent 
inactivation of INa. The size of this early repolarization (notch) greatly influences the time 
course of the other voltage-gated currents and, consequently controls the AP duration 
indirectly. Phase 2 results from a fine balance of inward depolarizing current (ICa,L*) and 
outward currents through delayed rectifier K+ channels (IKur, IKr† and IKs*) 181. The last 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* L-type Ca2+ current 
† Rapid delayed rectifier K+ current 
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phase of repolarization (phase 3) is the product of the increase in the conductance of 
the IKr, IKs and IK1 188. The resting membrane potential (phase 4) is maintained by 
inwardly rectifying K+ currents including IK1, IK(ATP)† and IK(Ach)‡. The ventricular AP differs 
in shape and duration among different species 200. While the AP in guinea pig cells 
displays a long-lasting plateau, the AP of mouse cells lacks phase 2 (Figure 1.6). In the 




Figure 1.6: Guinea pig (A) and Mouse (B) ventricular AP. For description see 1.4.2. 
 
1.4.3. Na+ current 
INa which generates the fast upstroke (phase 0) of cardiac AP was the focus of studies 
for more than half a century 62. It has been shown that voltage-gated Na+ channels 
underlie these currents and therefore are responsible for the AP upstroke as well as the 
rapid impulse conduction through cardiac tissue 16.  
These channels were the first voltage-gated ion channels to be cloned and sequenced 
in the 1980s 140. Voltage-gated Na+ channels are composed of a principal large pore 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Slow delayed rectifier K+ current 
† inwardly rectifying K+ current activated by ATP 
‡ inwardly rectifying K+ current activated by acetylcholine 
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forming α-subunit and small accessory β-subunits. By today, at least 6 separate genes 
encoding homologous α-subunit isoforms in human (Nav1.1- Nav1.6) have been 
cloned. These isoforms expressed in the brain, heart and skeletal muscle 8,67. The heart 
isoform, Nav1.5, which is encoded by the SCN5A gene, is the predominant α-subunit of 
the cardiac Na channels 66. Mutations in the SCN5A gene lead to various pathological 
phenotypes, such as long QT (LQT) syndrome type 3, Brugada syndrome, and the 
diseases of the heart conduction system 226. Accessory β-subunits appeared to have a 
primary role in regulating the subcellular localization of the α-subunits 89.  
The α-subunit is composed of four homologous domains (DI-DIV), each containing 6 
transmembrane segments (S1-S6) and a pore loop (Figure 1.7). The pore through 
which Na+ ions permeate, is formed by the S5-S6 segments along with their cytoplasmic 
linkers called pore loops (P-loop). Mutations in P-loop can completely disrupt the ion-
channel function 161. The fourth transmembrane segment (S4) in each of the 4 domains, 
which contains regularly arranged positive charges, works as a “voltage sensor” and 
responds to the membrane depolarization by a conformational change that results in 
channel pore opening and subsequent inward current 16. In domain III, a lysine critically 
selects for Na+ over Ca2+ and constructs the selectivity filter region 145. 
Voltage-gated Na+ channels inactivate rapidly after a very brief channel opening. A 
group of 3 hydrophobic amino acids in the linker between domains III and IV are 
proposed to be important for the channel inactivation 80 although other structures (S6 in 
domain IV and S4-S5 linkers) have also been suggested 127,189. Recovery form 
inactivation occurs when the membrane potential changes back to resting levels 
(negative Em) 23. 
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Figure 1.7: Structure of Nav1.5. Each of the four Na+ channel domains (DI–DIV) consists of six transmembrane α-
helices. The fourth segment (S4) contains regularly arranged positive charges that function as the voltage sensor. 
The intracellular loop between DIII and DIV forms the inactivation gate. The proximal C terminus is composed of six 
helices forming an EF-hand domain (EF) and a downstream calmodulin binding motif (IQ motif). Black regions (E6, 
E17, E18, E24, E28) are channel regions affected by alternative splicing. Taken from Schroeter et al, 2010 174. 
 
Unlike other voltage-gated Na+ channels, the cardiac Na+ channels are rather 
tetrodotoxin (TTX)-insensitive and can only be blocked by high concentrations (in mM 
range) of TTX. The Cys401 in the p-loop of the domain I of the cardiac Na+ channels, 
which is different from Phe or Tyr of the non-cardiac voltage-gated Na+ channels, has 
been proposed to underlie this low TTX sensitivity 14. The type I antiarrhythmic agents 
such as quinidine, procainamide, lidocaine can also block cardiac INa. The PKA-
dependent phosphorylation of the cardiac Na+ channels leads to a marked increase of 
INa by enhancing the maximal Na+ conductance 173. 
 
1.4.4. L-type Ca2+ current 
There are 2 types of Ca2+ currents in cardiac cells: T- and L-type Ca2+ currents. The 
channels responsible for these currents differ in their biophysical properties as well as 
drug sensitivity. L-type Ca2+ channels have a high conductance (~25 pS in 110 mM 
Ba2+), long openings, activation at larger depolarizations and sensitivity to 1,4-
dihydropyridines (DHP). In contrast, T-type Ca2+ channels display a tiny conductance 
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(~8 pS in 110 mM Ba2+), transient openings, activation at more negative Em and 
resistance to DHP 23.  
Moreover they have different functions in cardiac myocytes. The L-type Ca2+ current 
(ICa,L) which is a depolarizing current does not play a considerable role in the rapid 
upstroke phase of AP in atria, ventricle and His-Purkinje system, but it balances the 
outward K+ currents which leads to a plateau during the early repolarization phase. On 
the other hand, ICa,L triggers SR Ca2+ release and contributes to the refilling of the SR 
Ca2+ stores. In addition to its role in working myocytes, ICa,L is responsible for the 
relatively slow depolarization phase of AP in SA and AV nodes. 
Although T-type Ca2+ current (ICa,T) activation has the same Em-dependency as INa 
(activation at –50 mV), it does not play an important role in the AP depolarization. A tiny 
channel conductance and transient openings cause only a very small inward current 
compared to the large Na+ influx. Moreover, they do not contribute to EC Coupling for 
two reasons: (i) ICa,T is very small and (ii) T-type channels are not located in close 
proximity to the Ca2+ release channels of the SR 98. Some studies suggest that ICa,T has 
a role in atrial pacemaking 76.     
The L-type voltage-dependent Ca2+ channels (LVDCC) are composed of 4 subunits: the 
α1, α2/δ, β, and, in some tissues, γ  28 (Figure 1.8). The cardiac isoform lacks the γ  
subunit 110. While α1c builds the core of the cardiac LVDCCs (Cav1.2), the accessory 
(β2, α2/δ) subunits modulate the biophysical properties as well as trafficking of the α1c to 
the membrane 28.  
Similar to the α-subunit of other voltage-gated ion channels, α1c consists of 4 
homologous domains (I–IV), each composed of 6 transmembrane α-helices (S1 to S6). 
Various biophysical properties of the LVDCC such as channel pore (S5, S6 and their 
cytoplasmic linker), voltage sensor (S4), inactivation-related sequences (cytoplasmic C-
termini) and the binding sites of the channel modulators 38 are all determined by the α1c 
subunit. A congenital cardiac disease called Timothy Syndrome has been related to a 
mutation in the α1c subunit and specifically in the exon 8 of the Cav1.2 gene 183. 
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Figure 1.8: Structure of Cav1.2. The proposed membrane topology of the core subunit and interactions with auxiliary 
subunits are displayed. The pore-forming α-subunit consists of homologous domains (I–IV), each composed of 6 
transmembrane α-helices (S1 to S6). The numbers indicate the following regions: 1- Voltage-dependent activation 
kinetics 2- Interaction with β-subunit (I-II cytoplasmic linker) AID 3- BID 4- Voltage-dependent inactivation (IS6 and 
flanking regions) 5- Ion selectivity (pore-forming S5-S6 linker regions) 6- Voltage sensor (IS4, IIS5, IIIS4, IVS4) 7- 
Binding sites for DHP 8- EC coupling (II-III linker) 9- Role in use-dependent block 10- Binding sites for BTZ, DHP, and 
PAA 11- Ca2+–dependent inactivation (C terminal) 12- Phosphorylation site for CaMK-II (Ca2+/calmodulin dependent 
protein kinase) 13- Phosphorylation site for PKA. Taken from Bodi et al, 2005 28. 
 
The cardiac β2 subunit, which consists of a single cytosolic domain (Figure 1.8), 
interacts with α1c through a special sequence called the β-interaction domain (BID). It 
has been shown that the binding partner of BID on the α1c is a highly conserved 
sequence in the cytoplasmic linker between domains I and II, called the α-interaction 
domain (AID) 154. While α1c  dictates the biophysical characteristic of the channel, β2 is 
much more involved in the regulation of these properties 178. For instance, β2 has been 
postulated to be important for the expression, assembly 190 and trafficking of the α1c to 
the membrane 217. Moreover, the pore opening is augmented 217 and the DHP affinity is 
enhanced 133 by β2. The ICa,L increase in response to β-adrenergic stimulation is also 
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mediated by the β2 subunit 133. PKA-dependent phosphorylation of β2 subunit at 
positions Ser478 and Ser479 resulted in an increase of peak ICa,L 34. 
The α2/δ subunits are the products of one gene and are separated posttranslationally 48. 
The α2 is extracellular and is bound to the monomeric transmembrane δ subunit 
 through a disulfid bridge 28. The α2/δ are supposed to participate in the regulation of the 
biophysical properties of the channel with β2  23. These subunits increased the DHP 
sensitivity of the channel by 4-fold and accelerated the channel opening and closing 
208,59. 
ICa,L inactivates in a biphasic manner. Several studies proposed 2 different mechanisms 
for LVDCC inactivation: (i) Ca2+-dependent inactivation (CDI) and (ii) voltage-dependent 
inactivation (VDI) 109. CDI is a regulatory mechanism with which Ca2+ limits its own influx 
via LVDCC. This helps to reduce the risk of Ca2+ overload in the cell. CDI is primarily 
dependent on the Ca2+ release from the Ca2+ release channels of SR (RyR) 49 and is 
the predominant mechanism for LVDCC inactivation on the time scale of an AP 32. VDI 
On the other hand prevents a premature activation of the channel when CDI terminates 
159. 
CDI is mediated by a Ca2+ binding protein called calmodulin (CaM) 227,229. CaM has 
binding sites on the carboxy terminus of the α1c subunit, one of them is called IQ motif 2. 
CaM binds to these binding sites with a very high affinity, even at rest and in 
unsaturated state (when less than 4 Ca2+ ions are bound to CaM) 149. Em depolarization 
and intracellular Ca2+ increase lead to the binding of 4 Ca2+ ions to CaM. Ca2+-saturated 
CaM changes its conformation along with α1c, which leads to the closure of the channel 
pore 195. 
LVDCCs appeared to be regulated by different types of protein kinases such as PKA 
and PKC. PKA which is activated downstream to β-adrenergic stimulation, enhances 
the ICa,L by increasing the open probability as well as the open time of the channel 195. 
α1C has been shown to be the target for PKA-dependent phosphorylation 47. However, in 
vitro experiments showed a PKA-mediated phosphorylation of auxiliary β subunits, too 
68. A source of readily usable PKA is provided by mAKAP or AKAP15 in the vicinity of 
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LVDCCs 94. Activation of PKC downstream to various types of Gαq/11 protein-coupled 
receptors may also lead to channel phosphorylation 94. Although, this effect on the ICa,L 
can either be increasing 11 or decreasing 221. One possible explanation for this 
controversial effect is the GPCR-dependent production of IP3 along with PKC activation. 
IP3 could induce Ca2+ release from the SR which would induce CDI and counterbalance 
the ICa,L increase by PKC phosphorylation 101. Various pharmacological tools such as 
most of DHPs, phenylalkylamines (PAAs), and benzothiazepines (BTZs) can inhibit ICa,L 
28. On the other hand, some DHPs such as Bay K 8644 and CGP 28392 are Ca2+ 
channel agonists and enhance ICa,L 23.   
 
1.4.5. K+ currents 
Different types of K+ currents have been described in cardiomyocytes. Cardiac K+ 
currents have different biophysical properties such as various time- and voltage-
dependence and/or drug sensitivity. This variety results in their different physiological 
functions. The K+ currents shape the cardiac AP, drive Em toward EK, and regulate the 
heart rate. Furthermore, many hormones, neurotransmitters and drugs modulate the 
cardiac function by regulation of K+ channels 136,181. 
To simplify the study of K+ channels, different types of classifications were introduced. 
According to Tamargo, K+ channels can be classified as voltage-gated (Kv) and ligand-
gated K+ channels 188. The Kv channels were further categorized: (a) 4-AP sensitive, 
rapidly activating and inactivating currents, referred to as Ito (transient outward) and (b) 
TEA sensitive, slowly activating and inactivating outward currents referred to as delayed 
rectifier K+ currents 17. Table 1.2 shows members of each category and genes encoding 
for each channel. 
Kv channels are formed by coassembly of four pore-forming α subunits and ancillary β 
subunits. The α subunit consists of six transmembrane-spanning segments (S1–S6) 
with cytoplasmic N- and C-termini and a pore loop between S5 and S6 carrying the K+ 
selectivity filter signature TxGYG 181. The voltage sensor resides in the S4 segment. 
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Accessory β subunits modulate membrane trafficking, gating properties and drug 
sensitivity of the channel 79,123. Most Kv channels experience an inactivated state 
between open and close state and need a recovery phase for reactivation 188. 
 
Table 1.2: genes encoding for the α and β subunits of potassium channels. Taken from Tamargo et al, 2004 188. 
Current 













IKs Kv7.1 (KVLQT1) KCNQ1 Mink KCNE1 
IKr Kv11.1 (HERG) KCNH2 Mink KCNE1 
IKur Kv1.5 (HK2) KCNA5 Kvβ1 (Kvβ3) KCNAB1 
IK1 Kir2.1 (IRK1) KCNJ2   
 Kir2.2 (IRK2) KCNJ12   
IK(Ach) Kir3.1 (GIRK1) KCNJ3   
 Kir3.4 (GIRK4) KCNJ5   
IK(ATP) Kir6.2 (BIR) KCNJ11 SUR2A ABCC9 
Ito1 Kv4.3 KCND3 KChIP2 KCNIP2 
 Kv1.4 KCNA4   
 Kv4.1 KCND1 KChIP1 KCNIP1 
 Kv4.2 KCND2 KChIP2 KCNIP2 
 
In cardiomyocytes inwardly rectifying K+ currents have also been described, which 
include the members of ligand-gated K+ currents. The channels responsible for these K+ 
currents (Kirs) also contain α and β subunits, however the α subunit is different from 
those of Kv channels. Each Kirs’ α subunit consists of two transmembrane segments 
(M1 and M2) and a cytoplasmic linker 181.  
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1.4.5.1. Transient outward K+ current (Ito)  
The early rapid repolarization (phase 1) is mediated by 2 repolarizing currents: Ito1 and 
Ito2. The Ito1 conducts K+, can be blocked by 4-AP and is Ca2+-insensitive 70. In contrast, 
iIto2 conducts Cl- more than K+, is 4-AP insensitive and Ca2+-dependent 230,231. The Ito1 
and Ito2 modulate the gating of other repolarizing currents such as delayed rectifier K+ 
currents, by defining the height of the AP plateau (phase 2), thus determine the AP 
duration. The AP prolongation seen in heart failure, myocardial ischemia and infarction 
has been attributed to alterations of Ito such as reduced channel density 141. Moreover, 
Ito currents indirectly contribute to EC coupling by modulating the AP duration 141.  
In addition to the human heart, Ito1 has been also characterized in other species such as 
mouse 21 and rat 13. The Ito1 density differs between different regions of the heart. For 
instance, in human, rat, rabbit and dog the epicardium has a higher Ito density compared 
to the endocardium 144. The gene encoding for Ito1 was proposed to be Kv4.3 in human 
92 and Kv4.2 in rat 51 and mouse 20. 
PKC and PKA are candidates for Ito1 channel’s phosphorylation and regulation 188. While 
α-adrenergic stimulation showed a down-regulation of Ito1 in rat 12, β-adrenergic agonist 
had no effects on the current density 188. 
 
1.4.5.2. Delayed rectifier K+ currents (IKur, IKr, IKs) 
The members of delayed rectifier K+ currents contribute to the AP repolarization. They 
are classified as ultrarapid (IKur), rapid (IKr) and slow (IKs) currents based on their gating 
properties. Mutations of delayed rectifier K+ channels are involved in different types of 
human LQT syndrome 23.  
Among delayed rectifier currents, IKur activates the fastest, does not inactivate and is 
blocked by 4-AP 30. The IKur channels are encoded by KCNA5 60.  
Activation of IKr is faster than IKs, however they are both activated after Ito in the time 
course of an AP (Ito < IKur < IKr < IKs) (Figure 1.3). At positive potentials, IKr conducts an 
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inward current 218. Kr channels are also called HERG channels since the α-subunit of 
the channel is encoded by human ether-a-go-go related gene (KCNH2) 1. In HERG 
channels, the α-subunit is associated with accessory β-subunits such as mink and 
mirP1. The channel is highly expressed in human ventricular myocytes. Moreover 
higher IKr density has been also reported in rat atrial cells 151. Mutations in the HERG 
gene have been related to different types of LQT syndrome (See the Inherited 
Arrhythmia Database sponsored by Cardiovascular Genetics, New York University). For 
instance, cLQT syndrome, which is a complex disease described by massive QT 
interval prolongation and polymorphic ventricular tachycardia *  is attributed to the 
mutations of KCNH2 96,160. β-adrenergic stimulation regulates HERG channels by 2 
different mechanisms: (i) PKA-dependent phosphorylation and (ii) direct channel 
activation 205. Moreover, PIP2 modulates the biophysical properties of the channel that 
results in more hyperpolarized Em-dependent channel activation as well as IKr up-
regulation 24. Lanthanum and several members of class III antiarrhythmic drugs, 
including dofetilide, E-4031, and sotalol block IKr 167,168.  
IKs is composed of a pore forming α-subunit encoded by KCNQ1 and two accessory β-
subunits 39. The channel activation is very slow so that it never gets fully activated 
during a normal AP 23. Therefore it does not markedly contribute to AP repolarization. 
However, [Ca2+]i increase enhances IKs, and results in AP shortening that limits 
intracellular Ca2+ overload 194.  
 
1.4.5.3. Inwardly rectifying K+ currents (IK1, IK(Ach), IK(ATP)) 
In cardiomyocytes, inwardly rectifying K+ currents (IK1, IK(Ach), IK(ATP)) contribute to the 
resting membrane potential (VR) 17.  
In addition to the resting membrane potential, IK1 also contributes to the phase 3 of 
repolarization. It activates at negative membrane potentials and closes very fast upon 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Tordes de Pointes (TdP) 
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Em depolarization 188. Ba2+ is a strong IK1 blocker 213. In human ventricular myocytes, IK1 
can be stimulated by PIP2 and inhibited by isoproterenol and forskolin 117,170. 
In contrast to Kv channels, the gating of K(ATP) and K(Ach) channels are Em-independent. 
The gating of ATP-sensitive K+ channels is controlled by the [ATP]i. IK(ATP) is inhibited at 
physiological levels of [ATP]i 219 and stimulated in situations of massive [ATP]i drops. 
For instance during myocardial ischemia in which [ATP]i decreases, IK(ATP) becomes 
activated 137. The resulting K+ influx counterbalances the repolarizing currents and leads 
to AP shortening 137. This helps the cell to reduce its ATP expenditure by limiting 
excitation and subsequent contraction. This increases cell survival 73. 
Acetylcholine activated K+ currents (IK(Ach)) are preferentially expressed in cells of the 
SA and the AV node where they hyperpolarize Em and decelerate the heart rate. Some 
studies showed the presence of IK(Ach) in atrial cells 122. The acetylcholine effect is 
mediated by the βγ-subunits of members of the Gαi/o protein families 42. 
  
1.5. Action potential propagation in cardiac tissue 
The heart is a functional syncytium in which electrical impulses can propagate between 
the cells.	   In heart tissue, the electrical impulse is transmitted from one cell to the other 
via a special type of nonselective ion channels in the gap junction region of intercalated 
discs 98 (Figure 1.3). These channels are called connexons and consist of six connexin 
subunits, each of which has four transmembrane α-helices. Two connexons from 
neighboring cells build the gap junction that allows the longitudinal ion flow between 
cells. [Ca2+]i increase as well as acidosis lead to the closure of gap junction channels 
which is a safety mechanism to limit the distribution of toxic components to the 
neighbors.  
The velocity of AP propagation is ~ 0.5 m/s in human atrial and ventricular muscle. The 
complete activation of atria takes ~ 90 ms, while all the ventricular mass is activated by 
~ 230 ms 103. 
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1.6. Excitation-Contraction (EC) Coupling 
The electrical impulse that is initiated in the SA node transmits to the ventricular 
myocytes and results in membrane depolarizations and APs. This AP in turn leads to 
cardiomyocyte’s contraction. But how does this membrane depolarization cause 
activation of the contractile machinery? In cardiac cells, electrical excitation is coupled 
to contraction by the ubiquitous second messenger Ca2+, a process called EC coupling.  
 
	  
Figure 1.9: EC coupling in a cardiomyocyte. Several different ion channels, transporters, exchangers and contractile 
proteins contribute to this process. For description: see text. Taken from Bers 2002 22. 
 
The AP which is initiated in the surface membrane propagates along the surface and 
the t-tubules. The membrane depolarization causes the activation of LVDCCs, which 
results in Ca2+ influx. The LVDCC density is higher in t-tubules compared to surface 
membrane 99, which leads to the Ca2+ entry into the dyadic space. Therefore, the Ca2+ 
increases in the vicinity of RyRs and activates the Ca2+ release from the SR. This 
process is called Ca2+-induced Ca2+ release (CICR) 88 and amplifies the Ca2+ influx to a 
degree required for the activation of the contractile filaments 50 and subsequent 
contraction. The contraction is followed by a relaxation period that requires Ca2+ 
removal from cytosol. This is achieved by members of the Ca2+ removal machinery 
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including: (i) SR Ca2+-ATPase, (ii) sarcolemmal Na+/Ca2+ exchange, (iii) sarcolemmal 
Ca2+-ATPase, (iv) mitochondrial Ca2+ uniport 22 (Figure 1.9).  
β-adrenergic stimulation accelerates the contraction velocity by PKA-mediated 
phosphorylation of several proteins involved in EC Coupling such as LVDCC, RyR, 
phospholamban, troponin I and myosin binding protein C 22. 
Phospholamban is a protein that binds the SR Ca2+-ATPase and inhibits its activity. The 
phosphorylation of phospholamban results in its dissociation from the SR Ca2+-ATPase 
and the relief of inhibition 98. Troponin I as well as myosin binding protein C are the 
members of cardiomyocyte’s contractile machinery, thus contribute in contraction. 
 
1.6.1. SR Ca2+ release channels (RyR) 
CICR is mediated by the SR Ca2+ release channels. These channels have high affinity 
to a neutral plant alkaloid, ryanodine, thus also called ryanodine receptors (RyR). A 
group of 6-20 RyRs are normally activated synchronously in response to a unitary Ca2+ 
influx, leading to a local Ca2+ increase called Ca2+ spark 40. Ca2+ sparks are the 
elementary units of SR Ca2+ release during EC coupling. Tens of thousands of Ca2+ 
sparks are temporally synchronized by the AP to generate the global Ca2+ transient. In 
addition to their role as Ca2+ release channels, RyRs function as scaffolding proteins for 
other regulatory proteins involved in the CICR process. This helps to localize all 
important proteins for CICR at the sarcolemmal–SR junctions. For instance FKBP and 
calmodulin, which modulate the RyR gating properties and function respectively, are 
coupled to RyRs 64. The SR Ca2+ buffer, calsequestrin, is also coupled to RyR on its SR 
luminal side 223.  
 
1.6.2. Sarco/endoplasmic reticulum Ca2+-ATPase 
The Ca2+, which is released into the cytosol during systole, should be removed from the 
cytosol and/or taken up by the internal stores for the next EC coupling cycle. This is 
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majorly mediated by the sarco/endoplasmic reticulum Ca2+-ATPase type 2a 
(SERCA2a), the cardiac isoform of the SR Ca2+ pump 23. A small membrane protein 
called phospholamban regulates SERCA2a 98. Phospholamban inhibits the Ca2+ pump 
unless it is phosphorylated. Phosphorylation of phospholamban by either cAMP-
dependent protein kinase (PKA) or calmodulin-dependent protein kinase (CaMK-II) 
terminates the inhibition, speeds up the Ca2+ reuptake 22. The Ca2+ binding proteins in 
the SR lumen immediately buffer the pumped Ca2+ to maintain the normal SR Ca2+ 
concentration and avoid SERCA inhibition by Ca2+-sensitive SERCA regulators. 
Calsequestrin, the major Ca2+ buffer of the SR, has been shown to have 18 to 50 Ca2+ 
binding sites 98.   
 
1.6.3. Na+/Ca2+ exchange 
Sarcolemmal Na+/Ca2+ exchange is the most important pathway for Ca2+ removal from 
the cardiac cell. This ion exchange is achieved by means of a plasma membrane 
antiporter called Na+/ Ca2+ exchanger (NCX), which catalyzes the electrogenic transport 
of one Ca2+ for three Na+ 55. The Na+ gradient across the membrane (which is 
maintained by Na+/K+ ATPase), is used as a driving force for Ca2+ efflux (forward 
mode). However NCX might also work in the reverse mode (Ca2+ influx) during high 
[Na+]i or positive Em 50. KB-R7943, an isothiourea derivative, can selectively block NCX 
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1.7. Signal transduction in cardiomyocytes 
At the cellular level, the communication with the environment is made possible by 
employing signal transduction. These signaling systems help the cell to sense the 
external stimuli and respond appropriately by modulating its function. In multicellular 
organisms or tissues, these responses are very important for the function of the whole 
system.  
How do these systems work? An external stimulus, which could be a hormone or 
neurotransmitter, activates a receptor on the cell membrane. The ligand-receptor 
binding leads to the generation of different intracellular second messengers that 
stimulate a biological response either by activating or blocking cellular functions.  
The heart is also finely regulated in response to the body needs. The cardiac cells 
employ many different signaling systems to fulfill this regulatory function 98. These 
signaling cascades integrate information from many sources, thus enabling the heart to 
switch on or off appropriate responses when needed.  
The signaling-induced responses can be divided into two types. Non-genomic 
responses are developed rapidly in response to physiological stimuli such as exercise 
or blood loss. Whereas genomic responses are activated in response to chronic 
sustained stimuli such as cardiac overload induced by chronic hypertension. The latter 
is achieved by changes in gene expression and protein synthesis that results in 
structural and functional remodeling 98.  
Thus, knowledge about these signaling systems helps us to understand the cardiac 
function. However it is not so easy to study these signaling cascades due to the fact that 
they are not linear pathways, in which each step activates a single downstream 
molecule, but instead they branch and interconnect with other pathways forming 
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Figure 1.10: A model illustrating some signaling cascades in cardiomyocytes. Stimulation of β-adrenergic receptor (β-
AR) activates Gαs, which leads to the activation of PKA and subsequent phosphorylation of different members of EC 
coupling such as Cav1.2, RyR2 and PLN (phospholamban). The wave of phosphorylation enhances the [Ca2+]i and 
contractility. Intracellular Ca2+ increase activates CN/NFAT (calcineurin/nuclear factor of activated T-cells) and CaMK-
II signaling that contribute in myocyte hypertrophic response. Transcription factors, such as MEF2 (myocyte-
enhancer factor 2) and GATA4 (cardiac zinc finger transcription factor) are located in the nucleus and serve as 
endpoints for hypertrophic-signaling pathways. Stimulation of α-AR activates Gαq signaling, for description: see text. 
Image taken from Bodi et al, 2005 28. 
 
1.7.1. Gαq/11 signaling pathway 
G-protein mediated signaling contributes to various important physiological responses 
of cardiomyocytes. G-proteins are heterotrimeric GTP-binding proteins composed of α, 
β and γ subunits. Gα contains a bound guanine nucleotide. G-proteins are classified into 
4 groups (Gαs, Gαi/o, Gαq/11, Gα12/13) depending on the type of their α subunit 270. While 
in cardiomyocytes the role of most of these G-protein mediated signaling are well 
understood, Gαq/11 signaling is still not investigated in great details. When ligands such 
as epinephrine, endothelin-1 or angiotensin-II bind to GPCRs, induce a conformational 
change in the receptor that allows the GPCR to function as a guanine nucleotide 
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exchange factor (GEF). Activated receptor exchanges the GDP bound to Gαq for GTP 
that leads to Gαq activation and dissociation from βγ subunits 98. Activated Gαq 
stimulates PLCβ, an enzyme that hydrolyzes PIP2 to IP3 and DAG. IP3 induces SR Ca2+ 
release and DAG activates cPKCs and nPKCs. Both effects, i.e. intracellular Ca2+ 
increase and PKC-mediated phosphorylations, modulate the cardiomyocyte’s 
contractility (Figure 1.10).  
The Gαq/11 signaling scheme described above results in a non-genomic response to the 
body needs. However the physiological importance of this non-genomic response 
compared to Gαs signaling has not been well described in cardiomyocyte 192. In 
contrast, many studies proposed an important role for the Gαq/11 signaling cascade in 
pathological responses such as hypertrophy and heart failure 83. In humans, cardiac 
diseases develop over a long period of time, often years. Thus, the pathological 
responses of the Gαq/11 signaling are genomic responses associated with structural and 
functional remodeling 6,128. The impact of Gαq/11 signaling on the development of cardiac 
diseases has been the focus of study for many years and various biological tools were 
employed in these investigations. The overexpression of Gαq proteins in the heart 
resulted in hypertrophic response followed by heart failure 6,44. Inhibition of this signaling 
pathway by either expressing a Gαq/Gα11-inhibitory peptide or Gαq/Gα11 protein 
knockout abolished the pressure-overload induced hypertrophy 10,211. RGS is a 
GTPase-activating protein that can inhibit Gαq/11 signaling by inducing GTP hydrolysis. 
The overexpression of RGS4 in cardiac cells also reduced the hypertrophic response 
163.  
Besides the genomic responses, Gαq/11 signaling appeared to cause non-genomic 
pathological responses, too 120. Activation of the IP3 receptor type 2 (IP3-R2) 
downstream to Gαq/11 signaling results in the SR Ca2+ release 112. Such a secondary 
mechanism modulating Ca2+ signals, could interfere with the highly orchestrated Ca2+ 
responses mediated by the SR Ca2+ release channels, RyR, and might thereby 
predispose the cell to arrhythmogenic events 216. IP3-R2 can also initiate ectopic Ca2+ 
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transients 112, a potential source of ectopic beats*. It has also been suggested that any 
IP3-R2 located close to the sarcolemma, by causing local Ca2+ signals, could interfere 
with voltage-regulated Ca2+ channels to shorten AP duration. Local Ca2+ could also 
activate NCX to enhance Na+ entry 162. Slow release of Ca2+ by IP3-gated Ca2+ release 
channels is suitable for mediating the proliferative signals that regulate cellular 
processes such as protein synthesis, cell cycling and apoptosis 83. Unlike the short 
bursts of contraction and relaxation induced by CICR, IP3-mediated Ca2+ signaling 
results in a sustained Ca2+ release that allows for the activation of genes related to the 
hypertrophic response 53.  
These studies and many others focused on the relationship between cardiac diseases 
and Gαq/11 signaling cascade. While the basic physiological impact of such a signaling 
in cardiac cells remained unexplored. In this thesis I investigated the impact of Gαq/11 
signaling on cardiac electrophysiology. 
	  
1.7.2. Rac signaling pathway 
Rac1 belongs to the Rho family of small G-proteins. Rac1 and the other members of the 
Rho family (Rho and Ras) are activated downstream to integrin signaling (Figure 1.11). 
Integrin signaling contributes to protein synthesis and cell growth responses 105. 
Integrins are cell adhesion molecules that link the cytoskeleton to the extracellular 
matrix. Integrins activate members of the Rho family and many other signaling 
molecules such as various protein kinases (Akt, Raf, MEK and ERK) 69 in response to 
mechanical stress. The activation of these molecules initiates signaling pathways that 
modulate the interaction between integrins and the extracellular matrix 98. The integrin-
extracellular matrix interactions are specifically modified during the hypertrophic 
response of the heart to overload. Thus, as part of hypertrophic response activation of 
Rho family members and their downstream signaling participate in the responses to 
mechanical stress. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* irregular cardiac rhythm 
	   27	  
Activation of small G-proteins of the Rho family including Rac1 leads to the activation of 
different kinases such as PAK, MAPK, JNK family members 9,222 and PKA 121,209, which 
in turn modify protein phosphorylation. MAPK and JNK signaling contribute to various 
cellular responses such as cell growth 83. In cardiomyocytes, activation of these kinases 
has been linked to hypertrophic responses 204. Moreover, activation of PAK downstream 
to Rac1 signaling mediates the cytoskeletal reorganization at focal adhesion sites 184. 
 
	  
Figure 1.11: integrin signaling. Integrins activate the members of Rho family and many other signaling molecules 
such as various protein kinases (AKt, Raf, MEK, ERK) in response to the mechanical stress.  Activation of Rho family 
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The involvement of Rac1 in cardiac hypertrophic responses has been shown in both, in 
vitro and in vivo experiments 184. However, the underlying mechanisms for such 
structural and functional remodeling remained to be explored. 
Furthermore, Rac1 signaling leads to the activation of the NADPH oxidases (NOXes) 
that contribute to production of the reactive oxygen species (ROS). ROS are second 
messengers that induce both cellular physiological and pathological responses 85.  
Rac1 via ROS production activates downstream signaling molecules that modulate 
different cellular activities such as growth, differentiation and apoptosis. Moreover, ROS 
production has been linked to a plethora of cardiovascular diseases such as 
hypertension, inflammation and atherosclerosis 85. Thus, Rac1 signaling has high 
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1.8. Cardiac diseases 
Heart diseases are the most common diseases in the world and known to be the 
number one cause of death in western countries 95. Cardiac diseases were the focus of 
studies for many years. To date, it is obvious that most of the pathological conditions 
are associated with the remodeling of cardiac cells. This remodeling presumably alters 
the cellular function and reflects in cardiac dysfunction in the context of the whole heart. 
Although the knowledge about heart diseases is growing rapidly, there are still several 
uncertainties, which need to be investigated. Especially studies on the cellular level 
would support clinical approaches in their effort to prevent and treat heart diseases.  
  
1.8.1. Aldosterone  
Aldosterone is a hormone that is produced by the adrenal gland in response to 
physiological stimuli such as a drop in blood pressure. Aldosterone secretion is 
stimulated via the activation of the renin-angiotensin-aldosterone system 65 (Figure 
1.12). Renin is a peptide, which is secreted from the juxtaglomerular apparatus of the 
kidney and activates the enzymatic conversion of angiotensinogen to angiotensin-I. 
Angiotensin-I is then converted to angiotensin-II	  by the angiotensin-converting enzyme 
found in the lungs. Angiotensin-II, in turn, stimulates the aldosterone secretion from the 
adrenal gland. In a compensatory response, aldosterone increases the blood volume 
and therefore the blood pressure by enhancing the renal reabsorption of Na+ and water 
and the release of K+ in the kidney's nephral tubes. When aldosterone is released in 
excess, a condition referred to as hyperaldosteronism in humans, it can cause 
hypertension. Sustained hypertension, in turn, increases cardiac workload and causes 
cardiac hypertrophy 125.  
In addition to hypertension-induced cardiac injury, aldosterone has been proposed to 
have direct insulting effects on the heart. Several studies suggested an important role 
for aldosterone in the development of cardiac diseases such as human congestive heart 
failure 212. Moreover, hypertrophy which developed in the hypertensive rat model with 
higher levels of angiotensin-II and/or aldosterone, could be suppressed by 
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mineralocorticoid receptor (MR) antagonists at doses lacking antihypertensive effects 
33,138, suggesting a direct role for aldosterone in cardiovascular diseases 212. Clinical 
studies showed a close relationship between plasma aldosterone level and the left 
ventricular hypertrophy 212. MR antagonism could greatly rescue this phenotype.  
Although angiotensin-II and its downstream signaling have been studied extensively in 
the heart 83, little is known about aldosterone-mediated functions, and therefore it 





Figure 1.12: The schematic illustration of the Renin-Angiotensin-Aldosterone system. A drop in blood pressure (BP) 
stimulates the secretion of Renin from kidney which acts on Angiotensinogen and leads to the production of 
Angiotensin I. Angotesin converting enzyme (ACE) catalyzes the conversion of Angiotensin-I to Angiotensin-II that 
stimulates Aldosterone secretion from Adrenal gland. Aldosterone functions on three different target organs: (i) on 
Kidney it increases the reabsorption of sodium and water which results in the increased BP, (ii) on Arteries it induces 
vasoconstriction which leads to increased BP, (iii) on Heart its physiological impact is not well understood. Image 
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2. Materials & Methods 
2.1. Chemicals and solutions 
All chemicals used in this work were purchased, unless otherwise stated, from SIGMA-
ALDRICH, Invitrogen or VWR.  
All solutions used for preparation of ventricular myocytes and electrophysiological 
experiments are described in tables 2.1 and 2.2. 
 
Table2.1: Composition of the solutions used for preparation of ventricular myocytes. 
Chemicals MW 
Concentration (mM) 
CFS LCS CCS 
NaCl 58.44 134 134 134 
Glucose 180.16 11 11 11 
KCl 74.55 4 4 4 
MgSO4 120.37 1.2 1.2 1.2 
Na2HPO4 141.96 1.2 1.2 1.2 
HEPES 238.31 10 10 10 
DNase   0.045 0.09 
CaCl2 147.02  1 2 
pH  7.3 (NaOH) 7.3 (NaOH) 7.3 (NaOH) 
Osmolarity  300±10 300±10 300±10 
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Table 2.2: Composition of the solutions used for electrophysiological experiments. 
Chemicals MW 
Concentration (mM) 
Tyrode1 Tyrode3 IC1 IC2 
NaCl 58.44 135 135 10 10 
Glucose 180.16 10 10   
KCl 74.55 5.4  135  
HEPES 238.31 10 10 10 10 
CaCl2 147.02 1.8 1.8   
MgCl2 95.22 1 1 2 2 
CsCl 168.35  5.4  115 
4-AP 95.12  5   
TEA 165.7  5  20 
EGTA 380.35   0.1 0.1 
MgATP 507.18   3 3 








Osmolarity  300±10 300±10 300±10 300±10 
 
2.2. Preparation of rat ventricular myocytes 
Rat ventricular myocyte’s isolation and culture were performed according to a standard 
method established in our lab 191. Adult male Wistar rats (6 - 12 week old, 200 - 400 g) 
were anesthetized by an intraperitoneal injection (i.p.) of a mixture of 137 mg/kg 
ketamine hydrochloride (Ursotamin®, Serumwerk, Germany) and 6.6 mg/kg xylazine 
hydrochloride (Rompun®, Bayer Health Care, Germany). To prevent blood agglutination 
in the heart vessels, 20 mg/kg sodium citrate dihydrate was injected (i.p.) 10 min prior to 
surgery. After achieving deep anesthesia to suppress spinal cord reflexes, the animal 
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was killed by decapitation. The chest was opened; the heart was flushed with 10 ml of 
ice-cold Ca2+-free solution (CFS) (for chemicals see Table 2.1). Thereafter, the aorta 
was pinched off, the heart was removed, attached to a Langendorff apparatus and 
perfused retrogradely for 5 min with O2 saturated CFS containing 200 µM EGTA at 
room temperature. The perfusate was then changed to O2 saturated CFS containing 
0.17 mg/ml Liberase TM (Roche, Germany) for 20-25 min at 37 °C. After enzyme 
perfusion, the heart was removed from the apparatus. The ventricles were cleaned off 
of atria and vessels, cut to pieces and washed in O2 saturated CFS. In the next step, 
the ventricular tissue was incubated in 20-25 ml of O2 saturated CSF at 37 °C with 
gentle shaking for 5 min. Then the solution was discarded and the tissue was incubated 
in 20-25 ml of a low Ca2+-solution (LCS). The last incubation and washing step was 
done by 20-25 ml of O2 saturated Ca2+-containing solution (CCS). After this, a gentle 
trituration was applied to release the ventricular myocytes. The cell suspension was 
plated on the cover slips of a 12-well plate, which were coated with extracellular matrix 
proteins (ECM gel from Engelbreth-Holm-Swarm murine sarcoma, diluted to 12.5% with 
M199 medium). The cells were allowed to settle down for approximately 1 h in medium 
M199* containing 100 µg/ml Penicillin*, 100 µg/ml Streptomycin* and 50 µg/ml 
Kanamycin* (* PAA laboratories, Austria). The medium was supplemented with 870 nM 
insulin, 65 nM transferrin and 29 nM Na+-selenite (ITS supplemented medium). One 
hour after plating, the medium was changed for fresh medium supplemented with ITS. 
The myocytes were cultured in an incubator at 37 °C with a 5% CO2 atmosphere. 
Animal care was approved by the Animal Ethics Committee of the Saarland University 
and was performed according to the European directive on Laboratory Animals 
(86/609/EEC) and the Guide for Care and Use of Laboratory Animals published by the 
US National Institute of Health (NIH Publication No. 85-23, revised 1996). 
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2.3. Generation of transgenic mice 
2.3.1. Heart-specific inducible Gαq/Gα11 knockout 
The heart-specific inducible Cretg/0 mice and the Gαq/Gα11 mutant mice were provided 
by Prof. Dr. Stefan Offermanns (Max-Planck-Institute for Heart and Lung Research, Bad 
Nauheim, Germany). Transgenic Gαq/Gα11 KO mice were generated according to the 
method described in paper by Pahlavan et al 143. Mice carrying the gnaqflox/flox and 
gna11-/- alleles 211 were crossbred with the Cretg/0 mice to obtain gnaqflox/floxgna11-/-
Cretg/0 mice. Cretg/0 mouse was a novel mouse line in which Cre was flanked by mutated 
estrogen receptor binding domain (Cre-ER) and controlled by the α-myosin heavy chain 
(α-MHC) promoter. Gαq knockout was induced by 5-day consecutive tamoxifen injection 
(50 mg/kg body weight, i.p.) and accomplished 21 days after injection.  
 
2.3.2. Heart-specific inducible Cav1.2 I1624E mutation 
Mice carrying Cav1.2 I1624E mutation (I/E mice) were provided by Prof. Dr. Frank 
Hofmann (Institut für Pharmakologie und Toxikologie, Technische Universität München, 
Germany).  
Transgenic I/E mice were generated according to the method described in paper by 
Poomvanicha et al 152. To generate these mice, the heterozygous Cav1.2+/I1624E mice 
were crossbred with Cav1.2flox/flox 176 and MerCreMer* mice 182. The resulting offspring 
included Cav1.2flox/flox x MerCreMer (identified as knockout), Cav1.2flox/I1624E x 
MerCreMer (I/E), Cav1.2+/flox x MerCreMer (control) and Cav1.2+/flox (wildtype). A 4-day 
tamoxifen injection regime (100 mg/kg body weight, i.p.) was employed to induce 
Cav1.2 KO. All experiments were performed 10 days after the first tamoxifen injection, 
which was proved to be sufficient for the Cav1.2 KO 27.   
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* tamoxifen inducible Cre recombinase under the control of the α-MHC promoter 
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2.3.3. Heart-specific constitutively active Rac1 
Transgenic RacET mice (expressing constitutively active Rac1 under the control of the 
α-MHC promoter) were generated 184 and provided by Prof. Dr. Mark Sussman group 
(Heart institute, San Diego state university, CA). RacET mice were compared with age-
matched FVB-N mice (genetic background for RacET mice, designated as WT) in all 
experiments. 
 
2.4. Aldosterone Pump implantation 
Pump implantation was performed by Dr. Kathrina Wiesen (Institute for Molecular Cell 
Biology, Saarland University Homburg). Osmotic mini-pumps (Alzet®, DURECT 
corporation, model 2002) were filled with 200 µL of aldosterone (2 mg/mL; 25 mg 
aldosterone diluted in 10.875 ml propylenglycol, 1.175 ml ethanol and 0.5 ml distilled 
water) and were implanted subcutaneously in 8-week old mice in order to provide a 
constant release rate of 7.2 µg/day for 42 days. In control mice, empty pumps (dummy) 
were implanted. In the end of 42-day hormone infusion period, plasma aldosterone level 
was assessed using ELISA test (DRG instruments, Germany). 
 
2.5. Preparation of mouse ventricular myocytes 
The isolation of mouse ventricular myocytes was performed according to a standard 
method established in our lab 143. Mice (10 - 14 weeks old, 25 - 30 g) were anesthetized 
by injection of a mixture of 85 mg/kg ketamine hydrochloride and 15 mg/kg xylazine 
hydrochloride (i.p.). Sodium citrate dehydrate (10 mL/kg body weight) was used to 
prevent blood clot in the heart vessels. After achieving deep anesthesia to suppress 
spinal cord reflexes, the animal was killed by decapitation. The chest was opened and 
the lungs were removed. The remaining blood in the heart was washed out by flushing 2 
mL ice-cold CSF into the ventricles. Then the aorta was cut off; the heart was 
cannulated to allow retrograde Langendorff-perfusion. The heart was primarily perfused 
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with CFS (O2 saturated, containing 200 µM EGTA) at room temperature for 5 min and 
then with Liberase TM (0.085 mg/ml, diluted in O2 saturated CFS) at 37 °C for 12 min. 
After enzymatic digestion, the atria and vessels were removed; the ventricles were cut 
open and incubated in 10-20 mL O2 saturated CFS containing 0.09% DNase for 5 min 
at 37 °C. Then, the solution was discarded and the ventricles were incubated in 5 mL 
CFS containing 0.09% DNase for another 5 min. After these washing steps, ventricles 
were gently triturated and diluted with O2 saturated CCS gradually (10 x 150 µL CCS, 
every 5 min). The cell suspension was plated on ECM-coated coverslips of a 12-well 
plate and incubated for 1 hour at 37 °C, 5% CO2. After 1 hour, the supernatant was 
replaced by fresh medium M199. Animal care was performed according to the Guide for 
Care and Use of Laboratory Animals published by the US National Institute of Health 
(NIH Publication No. 85-23, revised 1996). 
 
2.6. Patch-clamp setup 
The patch-clamp setup was consisted of an inverted microscope (TE-2000, Nikon, 
Japan) resided on a vibration isolation table (CVI Melles Griot, Germany) inside a 
Faraday cage, an EPC 10 patch-clamp amplifier (HEKA Elektronik, Germany), a 
micromanipulator (Luigs & Neumann, Germany) holding the amplifier probe and a 
computer. The vibration isolation table was used to reduce vibrations beyond a few Hz, 
which is usually sufficient for the purpose of patch clamping. The patch-clamp 
preamplifier was surrounded by a Faraday cage to shield the sensitive amplifier probe 
from the electrical noise. 
EPC 10 system was consisted of the head stage (or probe) and the amplifier main unit. 
The probe, which was in a small enclosure, was mounted on the micromanipulator. The 
main unit was contained the signal processing electronics, the A/D and D/A converters 
and the connectors for analog and digital input/output. 
The micromanipulator was used to control the movements of the patch pipette (beyond 
submicrometer range) in order to finely position the patch pipette tip on the cell. 
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Data acquisition and analysis was performed using “Patchmaster” and “Fitmaster” 
softwares (HEKA), respectively. 
 
Figure 2.1: Patch-clamp setup. 
 
2.7. Patch-clamp technique 
The patch-clamp technique enables us to record macroscopic whole-cell or microscopic 
single-channel currents through the ion channels of biological membranes 165. In the 
patch-clamp technique, it is possible to experimentally control and modify the voltage of 
membrane patches or the whole cell (voltage-clamp), which allows us to investigate the 
voltage dependence of ion channels. Furthermore, the experimenter can monitor the 
changes of membrane potential in response to membrane currents (current-clamp). 
Therefore, the patch-clamp technique is a powerful tool to study cells 
electrophysiologically. 
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2.7.1. Electrophysiological experiments 
The electrophysiological experiments were performed using an EPC10 patch-clamp 
amplifier controlled by “Patchmaster” software (HEKA). 
The experiment was started by transferring the cells into the patch-clamp setup. To do 
so, the coverslip containing the ventricular myocytes were mounted into a custom-made 
chamber and transferred onto the stage of an inverted microscope. During the 
experiment, the cells were visualized using a CCD color camera (JVC professional 
products, USA). The cells were supplied by a bath solution, which had the ionic 
composition very similar to the interstitial fluid. This solution was permanently refreshed 
by a gravity-fed, valve-controlled perfusion system in combination with a custom-made 
suction system. Depending on the type of the experiment, different compositions of bath 
solution were used (see Table 2.2). Then the patch-pipette with the tip opening of 2-2.5 
µm was prepared by a pipette puller (DMZ Universal puller, Zeitz instruments, 
Germany) and filled with the pipette solution. Similar to the bath solution, various 
compositions of pipette solutions were used depending on the type of the experiment 
(see Table 2.2). The pipette was then connected to the preamplifier via a pipette holder 
and approached to the chamber by a micromanipulator. As soon as the pipette entered 
the bath solution, a current could be observed in the oscilloscope window (Figure 2.2) 
resulting from repetitive application of a -5 mV voltage pulse to the electrode by the 
amplifier. After entering the bath solution, a positive pressure was applied to get rid of 
cell debris and to avoid the occlusion of the pipette tip. Liquid junction potential i.e., 
potential differences between bath and intracellular solutions, was calculated for each 
pair of Tyrode and IC using a junction potential calculator and corrected from the 
voltage readings of the amplifier. The pipette was then approached to the cell. Then the 
pipette was positioned on the cell membrane and a gentle suction was applied to the 
pipette to form a gigaseal. 
The gigaseal was formed when the resistance between the pipette and the cell 
membrane increased to the values >109 Ω (Figure 2.2). Additional suction was applied 
to rupture the membrane patch under the pipette and to provide access to the cell 
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interior. By doing so, the “whole cell configuration” was obtained which could be 
identified by a current change in the oscilloscope window (Figure 2.2). This current had 
two components: (i) capacitive transients (Ic) and (ii) steady-state current (Iss) that the 
former should be omitted from the measurements. Capacitive transients could be 
estimated and cancelled by the amplifier. The cancellation was done by supplying the 
current needed to charge the capacitor (plasma membrane) 165. After establishing a 
successful whole cell configuration and before starting the measurements, a 2-4 min 
interval was considered for complete exchange of the intracellular solution with pipette 
solution. Then the AP and various ionic currents were recorded in the current-clamp and 
voltage-clamp mode, respectively. 
 
 
Figure 2.2: Sequence of pipette potentials (Vp) and pipette currents (Ip) during establishment of the whole cell 
configuration. Taken from the laboratory manual of the graduate school calcium signaling and cellular nanodomains, 
2009. 
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In the voltage-clamp experiments, the access resistance between the pipette and the 
cell interior should be considered, while it constitutes a resistance (Rs) in series with the 
membrane resistance (ion channels) that results in inaccurate membrane voltage 
readings. Therefore, in all voltage-clamp experiments, the Rs was compensated by the 
amplifier up to 70%. 
 
2.7.2. Action potential recording in ventricular myocytes 
The pipette solution and the bath solution for AP recording were IC1 and Tyrode1, 
respectively (Table 2.2). After establishing the whole cell configuration, the amplifier 
was switched to the current-clamp mode. AP was evoked by the repetitive injections of 
4-ms depolarizing currents, starting from I=100 pA with 100 pA increments at 1 Hz (RT) 
and 4 Hz (37 °C), until an overshoot > 5mV is reached. Signals were acquired at 50 kHz 
sampling frequency, filtered at 2.9 kHz and 10 kHz, and 3 consecutive APs were saved 
for further analysis.  
VR was determined by the voltage recorded at rest in the current-clamp mode (Figure 
2.3). AP amplitude was calculated as the voltage difference between VR and AP 
overshoot (Figure 2.3). Time to peak (TTP) was calculated as the time required for 
reaching the AP overshoot. Signal 4.02 (Cambridge electronic design Ltd, Cambridge, 
UK) was used for analysis of AP durations. AP durations at 30%, 50%, 70% and 90% of 
repolarization (APD30, APD50, APD70, APD90), were analyzed using a custom-made 
macro of Signal software. 
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Figure 2.3: Schematic illustration of AP amplitude and AP durations. 
 
2.7.3. Transient outward current (Itoc) measurement 
For Itoc measurements, the pipette was filled with IC1 and the cells were perfused with 
Tyrode1. Itoc was activated by a series of 500 ms test pulses ranging from -30 to +60 
mV with 10 mV increments from a holding potential of -120 mV (50 ms). Each test pulse 
was preceded by a depolarizing step to -40 mV (50 ms) to voltage inactivate INa 23 
(Figure 2.4).  
Data were recorded at 20 kHz sampling frequency and filtered at 2.9 kHz and 10 kHz.  
Itoc was obtained by subtraction of the end current from the peak current amplitude 
(Figure 2.4). The current amplitude was normalized to the CM in order to facilitate the 
comparison of the Itoc recorded in different cells with various sizes, and presented as 
current density (pA/pF). The current densities were plotted against the applied voltage 
pulses in Prism (GraphPad Software Inc., La Jolla, USA) and presented as current-
voltage (IV) relationships. 
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Figure 2.4: Itoc measurement. Illustration of protocol used for the Itoc recording (A), typical Itoc recording (B), and 
analysis of the Itoc amplitude (C). 
 
2.7.4. L-type Ca2+ current (ICa,L)  measurement 
To record L-type Ca2+ currents, IC2 was used as pipette solution (Table 2.2). Ventricular 
myocytes were perfused with Tyrode 3 (Table 2.2). In whole cell configuration and 
voltage-clamp, a series of 250 ms test pulses ranging from -50 to +50 mV with 10 mV 
increments were used to activate ICa,L. Each test pulse was preceded by a depolarizing 
step to -40 mV (150 ms) to voltage inactivate INa 23. To gain ICa,L, the end current was 
subtracted from the peak current (Figure 2.5 C). The resulting currents were normalized 
to the CM and plotted against the applied voltage pulses as IV relationships. To have 
more accurate ICa,L amplitude, leak current was measured prior to each ICa,L recording 
and subtracted from the Ca2+ current. Leak current was activated by application of a 
+30 mV test pulse in a voltage range where voltage-dependent channels are not active. 
Therefore, 4-time depolarizing pulses from -120 to -90 mV for 250 ms were applied; the 
resulting currents were averaged, scaled and subtracted from the current activated by 
the main test pulse.  ICa,L was obtained as the peak current amplitude, normalized to CM 
and plotted as IV relationships (IV curve).  
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Figure 2.5: ICa,L measurement. Illustration of pulse protocol used for the ICa,L recording (A), typical ICa,L recording (B), 
analysis of the ICa,L amplitude and ICa,L inactivation (C), and integration of ICa,L (D). For detailed description see 2.7.4. 
 
The time constants of ICa,L inactivation (τ1 and τ2) were obtained by a non-linear fit from 
the peak current to the end current (ICa,L at 0 mV test pulse) using a two-exponential 
function of “Patchmaster” software:  
𝑦 𝑥 = 𝐴𝑚𝑝! + 𝐴𝑚𝑝!!!!! 𝑒
!!
!!     Equation 2.1 
The amount of charge entry via ICa,L was calculated by integration of ICa,L trace (ICa,L at 0 
mV test pulse). The integration has been done using the online analysis methods of 
“Fitmaster” software (HEKA). To define the range for integration, the left cursor (C1) was 
set at the beginning and the right cursor (C2) at the position where the current was 
completely inactivated (Figure 2.5 D). In figure 2.5 D, the integral is shown as the 
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2.8. Photometry system 
The photometry system (TILL Photonics, Germany) consisted of a monochromator 
(polychrome IV), two Avalanche photodiode-based fluorescence detectors, the 
fluorescence detection unit (a microprocessor controller board) and a polychrome 
manual controller (PMC). For CICR gain measurements, this system was incorporated 
into the Patch-clamp setup and interfaced to the “Patchmaster” software. Indo-1, an 
emission ratiometric fluorescence dye, was used to measure [Ca2+]i. To excite this 
fluorescence probe, excitation light at 355 ± 7 was produced by a monochromator, 
reflected into the objective by dichroic mirror 1 (DM 380 LP) and focused on the dye-
loaded cell through an immersion objective (40x /1.30 oil, Plan Fluor, Nikon). The 
emission light was collected by the same objective and splitted into two channels by 
dichroic mirror 2 (DM 440 LP). The two emission wavelengths were detected by 




Figure 2.6: The excitation and emission spectra of Indo-1. Modified from Carlson and Campbell, 2009 37. 
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2.9. Excitation-contraction coupling gain measurements 
For EC coupling gain measurements, ventricular myocytes were perfused with Tyrode3. 
The pipette was filled with EGTA-free IC2 containing 0.1 mM Indo-1 pentapotassium 
salt (Indo-1). Indo-1 was dissolved in water and kept as 10 mM stock solutions at -20 °C. 
After establishing the whole cell configuration and before recording, a 7-min loading 
time was considered to ensure complete exchange of the intracellular solution with the 
pipette solution according to the test experiments. ICa,L and SR Ca2+ release were 
activated and recorded simultaneously using combination of patch-clamp and 
photometry system. ICa,L was activated by a pulse protocol similar to that explained in 
2.7.4. Additionally, each test pulse was preceded by 10 times 250-ms depolarizing 
pulses to 0 mV from a holding potential of -40 mV (Figure 2.7). In the gain 
measurements these prepulses were applied to obtain steady-state SR Ca2+ loading. 
During ICa,L recording, the Indo-1 was excited by photometry system and fluorescence 
was measured from a field slightly larger than the cell under study. The fluorescence 
signals were digitized at 0.5 KHz by an analog-to-digital converter of the EPC-10. Indo-1 
based Ca2+ signals were analyzed in Igor Pro 6.22 (WaveMetrics Inc., Oregon, USA) 
software. After background correction, two emitted wavelengths were ratioed and the 
amplitude of the resulting signal was calculated. EC coupling gain was calculated by 
ratioing of the Ca2+ signal amplitude over ICa,L density. The resulting Ca2+ current 
density, Ca2+ signal amplitude and EC coupling gain were plotted against the 
corresponding voltage pulses in Prism (Graphpad). 
 
 
Figure 2.7: Schematic presentation of the protocol used for EC coupling gain measurements. Ten times 
depolarization to 0 mV to induce steady-state SR Ca2+ loading and ICa,L recording after 20 s interval. Recording of the 
Intracellular Ca2+ transients was performed simultaneous with ICa,L measurements. 
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2.10. Data statistics 
Statistical analysis was performed in Prism (Graphpad) by using the appropriate tests 
(unpaired t-test, Mann-Whitney-Test, one-way ANOVA, Kruskal-Wallis-Test and two-
way ANOVA) chosen depending on the results of the normality test (D‘Agostino & 
Pearson omnibus normality test).  
Data are displayed as mean ± SEM for Gaussian distributed and median ± 25/75 
percentiles for non-Gaussian distributions. Asterisks indicate significant differences. 
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3. Results 
3.1. The effects of Gαq/Gα11 knockout on the basic 
electrophysiological properties of ventricular myocytes 
In cardiomyocytes, Gαq/11 signaling mediates the regulatory function of many hormones 
such as endothelin-1, angiotensin-II and epinephrine. Although its physiological 
relevance may not be as well established as Gαs signaling, Gαq/11 signaling has been 
shown to play an important role in the development of cardiac diseases such as 
hypertrophy and heart failure 130,166. Pathological Gαq/11 signaling has been investigated 
extensively using different biological tools, from in vitro assays to the generation of 
transgenic animals 83. However most of these studies did not consider the contribution 
of Gαq/11 signaling to basic physiology of a cardiomyocyte, including excitability and 
contractility. Here we used a novel transgenic mouse model with cardiac specific 
inducible Gαq/Gα11 KO (see 2.3.1) to study the possible contribution of these signaling 
cascades to the basic physiological properties of ventricular myocytes.  
 
3.1.1. Gαq knockout modulates the electrophysiological properties of 
ventricular myocytes 
Heart-specific Gαq KO mice were generated using the inducible Cre/LoxP system (see 
2.3.1). The Gαq KO was induced on Gα11 null-background mice, since Gαq and Gα11 
showed to have overlapping functions 5. To do so, mice with a GqflG11-Cre+ genotype 
(abbreviations in Table 3.1), either received a tamoxifen injection (Gαq/Gα11 double KO 
[DKO], red) or were kept without any treatment (Gα11 KO, turquoise). Gαq KO effects 
were studied by comparing DKO with Gα11 KO.  
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Table 3.1: Transgenic animals used to study the physiological role of Gαq and/or Gα11 proteins. wt, wildtype; tg, 
transgenic; 0, no Cre expression. Color-code in figures is identical.  
Label gnaq gna11 Cre status Tamoxifen Miglyol 
Gqfl G11- Cre+ Tam- flox/flox -/- tg/0 - - 
Gqfl G11- Cre+ Tam+ flox/flox -/- tg/0 + - 
Gqwt G11wt Cre- Tam- wt/wt wt/wt 0/0 - - 
Gqwt G11wt Cre- Tam+ wt/wt wt/wt 0/0 + - 
Gqfl G11- Cre- Tam- flox/flox -/- 0/0 - - 
Gqfl G11- Cre- Tam+ flox/flox -/- 0/0 + - 
Gqwt G11wt Cre+ Tam- wt/wt wt/wt tg/0 - - 
Gqfl G11wt Cre- Tam+ flox/flox wt/wt 0/0 + - 
Gqfl G11wt Cre+ Tam+ flox/flox wt/wt tg/0 + - 
Gqwt G11wt Cre- Mig+ wt/wt wt/wt 0/0 - + 
Gqfl G11- Cre+ Mig+ flox/flox -/- tg/0 - + 
 
In electrophysiological experiments, AP was studied as an integrative parameter since 
its shape reflects the contribution of all voltage-gated ion currents. Therefore, AP can be 
used as in indicator for changes in ion channel contributions. Furthermore, plasma 
membrane capacitance (CM), which provides information about the cell membrane area 
including the surface membrane and the t-tubular system, was assessed. Deletion of 
the Gαq protein resulted in a 12% reduction of the cell membrane area (Figure 3.1A, 
red). One of the possible reasons underlying CM reduction might be t-tubular loss, which 
was observed in many cardiac diseases 207. T-tubular loss could affect functional 
properties of cardiac myocytes such as EC coupling. However, CM measurements alone 
are not sufficient to verify this but could motivate further experiments investigating this 
possibility.  
VR was determined in both DKO and Gα11 KO cells and the results showed no effect of 
Gαq KO on this particular parameter (Figure 3.1B).  
APs were evoked in ventricular myocytes of DKO and Gα11 KO mice. All AP 
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measurements were performed at room temperature. The AP analysis showed a 10% 
reduction of the AP amplitude in DKO (Fig.3.1C, red). Figure 3.1Da demonstrates an 
exemplified AP from each group indicating AP prolongation in DKO cells. This 
observation was further confirmed by analyzing the time coarse of APs, quantitatively. 
APD30 and APD50 were used as indicators for studying the early repolarization while 
APD70 and APD90 served to characterize the late repolarization. The statistical analysis 
of early and late repolarization showed the prolongation of late repolarization, as 




Figure 3.1: The effects of Gαq KO on the electrophysiological characteristics of ventricular myocytes. Membrane 
capacitance (CM), resting membrane potential (VR), and action potential amplitude (AP amplitude) (A–C). 
Representative APs (Da) and action potential durations after 30, 50, 70 and 90% repolarization, APD30 and APD50 
(Db), APD70 and APD90 (Dc). Number of animals and cells are shown in Supplementary table 1. Error bars represent 
mean ± SEM. The box plots show median (middle band) and 25/75 percentiles (lower/upper quartiles, respectively).  
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The repolarization of the AP is brought about by the activation of many different K+ 
currents of which a few might be under the control of Gαq/Gα11-protein signaling as 
suggested previously 25,131. Wagner et al. showed recently that the Gα11 protein might 
contribute to the regulation of Ito 202. Therefore I also investigated the effects of Gαq on 
Ito by recording this current in ventricular myocytes lacking this protein. 
 
	  
Figure 3.2: The effect of Cd2+ on transient outward current (Itoc) density. Representative Itoc traces (A) and 
corresponding current-voltage (IV) relation curve of Itoc (B) in the presence and absence of Cd2+ in the bath solution to 
block ICa,L. Error bars represent mean ± SEM.  
 
Ito recording requires a special composition of bath and pipette solutions. These 
solutions are needed to block contaminating currents, in particular ICa,L. Consequently, 
AP and Ito recordings would require different sets of bath and pipette solutions. In order 
to optimize the throughput of measured cells, I decided to use the same solutions 
anyhow. Since ICa,L displayed an almost 5-fold lower current density, this approach 
appeared appropriate. Nevertheless, I performed control experiment with the ICa,L 
blocker, Cd2+ *  (0.1 mM)	   to verify this (Figure 3.2) and indeed found very little 
contamination by ICa,L. I refer to this current as Itoc (transient outward current) throughout 
this thesis due to the possible minor contaminations.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* CdCl2  
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Figure 3.3: The effect of Gαq KO on the transient outward current (Itoc) in ventricular myocytes. Typical Itoc traces (A), 
corresponding current-voltage (IV) relationships (B), and the Itoc density at +60 mV test potential (C). Number of 
animals and cells are shown in Supplementary table 1. Error bars represent mean ± SEM.  
 
Interestingly, Gαq KO reduced the Itoc density and altered its IV relationships (Figure 
3.3B, red). The maximum reduction of current density was at +60 mV, 16.6 ± 2 (pA/pF) 
in DKO compared to 23.8 ± 3 (pA/pF) in Gα11 KO (Figure 3.3C). 
In summary, heart-specific inducible Gαq KO modulated many of the investigated 
electrophysiological parameters (CM, AP amplitude, APD70, APD90 and Itoc). At this point, 
I was concerned whether all effects that I have seen were solely caused by the Gαq KO, 
or other experimental conditions such as tamoxifen injection, the Gα11 KO and/or Cre 
expression were contributing to the observed phenotype. Therefore, another set of 
experiments was designed to specifically address the following questions: (i) the impact 
of tamoxifen (ii) the effects of Cre expression (iii) the effects of Gα11 KO and (iv) the 
optimized set of genotypes to study Gαq KO effects. 
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3.1.2. Tamoxifen alters the electrophysiological properties of 
ventricular myocytes 
Tamoxifen is a selective estrogen receptor modulator (SERM) 65 and is widely used in 
the treatment of breast cancer 61. Previously, scientists developed an inducible knockout 
system based on tamoxifen for temporal control of gene knockout 81. In this technique, 
Cre is bound to a mutated form of the estrogen receptor that is no longer responsive to 
estrogen but is activated by tamoxifen. Tamoxifen activates Cre-ER* recombinase that 
removes genomic DNA between the two loxP sites 81. In our Cre/LoxP system, we used 
an injection regime comprising administration of tamoxifen on five consecutive days 
(see 2.3.1) to induce Gαq KO. All experiments were performed 28 days after the last 
injection. As suggested previously, tamoxifen’s half-life is supposed to be five days 
(t1/2=5 days) 115; therefore, its concentration should be reduced to below 2% after 28 
days (Figure 3.4). This remaining tamoxifen concentration was assumed to be 
inefficient. However, we checked this hypothesis by application of a similar tamoxifen 
injection regime in wildtype mice. As mentioned before, we performed our inducible Gαq 
KO on a Gα11-null background to avoid overlapping functions of these proteins. To 
further investigate the possible effects of tamoxifen in our system, the same strategy 
was used in Gα11 KO mice.  
 
	  
Figure 3.4: Tamoxifen pharmacokinetics. T1/2 shows the half-life of tamoxifen and T=28 indicates the start of 
electrophysiological experiments. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Cre bound to a mutated form of the estrogen receptor (ER) 
T1/2
T=28
	   53	  
Tamoxifen injection in wildtype mice did not affect CM, VR, AP amplitude and AP shape 
(Figure 3.5, brown vs. grey). Although APD30 and APD50 were not altered, Itoc showed a 
significant increase in tamoxifen treated wildtype mice (Figure 3.6A, brown vs. grey), 
which is reflected in IV curve, too (Figure 3.6B, brown vs. grey).  
 
	  
Figure 3.5: The effects of tamoxifen application on the electrophysiological characteristics of ventricular myocytes 
from wildtype and Gα11 KO animals. Membrane capacitance (CM), resting membrane potential (VR), and action 
potential amplitude (AP amplitude) (A–C). Representative APs (Da) and action potential durations after 30, 50, 70 
and 90% repolarization, APD30 and APD50 (Db), APD70 and APD90 (Dc). Number of animals and cells are shown in 
Supplementary table 1. Error bars represent mean ± SEM. The box plots show median (middle band) and 25/75 
percentiles (lower/upper quartiles, respectively). 
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Figure 3.6:	   The effect of tamoxifen application on the transient outward current (Itoc) of ventricular myocytes from 
wildtype and Gα11 KO animals. Typical Itoc traces (A), corresponding current-voltage (IV) relationships (B), and the Itoc 
density at +60 mV test potential (C). Number of animals and cells are shown in Supplementary table 1. Error bars 
represent mean ± SEM.  
 
The results of electrophysiological characterization in Gα11 KO mice were rather 
unexpected since they showed some discrepancies to the results found in wildtype 
mice. While, the tamoxifen treatment did not alter CM, VR and AP amplitude (Figure 
3.5A-C, violet vs. green), AP was prolonged in Gα11 KO mice (Figure 3.5Da, violet vs. 
green). This was further confirmed by analyzing the time course of AP repolarization 
(APDs). Both early and late repolarization periods were significantly slowed down in 
cells from tamoxifen-injected mice (Figure 3.5Db & Dc, violet vs. green). Itoc was 
significantly reduced in tamoxifen treated-Gα11 KO mice (Figure 3.6A, violet vs. green), 
which was in agreement with the results of early repolarization (Figure 3.5Db, violet vs. 
	   55	  
green). While the current-voltage relationships were significantly different in tamoxifen-
injected wildtype mice  (Figure 3.6B, brown vs. grey), the Itoc density at +60 mV was not 
(Figure 3.6C, brown vs. grey). A possible explanation for this apparent discrepancy 
could be that the sample size at +60 mV might be the limiting factor for statistical 
analysis.  
I also investigated the impact of miglyol, the tamoxifen solvent, on the 
electrophysiological characteristics of ventricular myocytes. Similar to tamoxifen 
experiments, miglyol effects were studied in both wildtype and Gα11 KO mice following 
the same injection regime.  
Miglyol injection into wildtype mice (2.5 ml/kg body weight) resulted in a significant 
decrease of CM compared to tamoxifen treatment (Figure 3.7A, sapphire vs. grey). 
Similar to tamoxifen, VR, AP amplitude (Figure 3.7B & C, sapphire vs. brown) and AP 
shape (Figure 3.8, sapphire vs. brown) were not altered by the miglyol treatment in 
wildtype mice. Furthermore, miglyol injection did not modulate the electrophysiological 
properties of Gα11 KO cardiomyocytes (Figure 3.9 and 3.10). 
Moreover, these sets of experiments enabled us to obtain information about the 
electrophysiological effects of Gα11 KO in ventricular myocytes. Gα11 KO resulted in a 
substantial decrease in CM (28%) (Figure 3.5A, brown vs. violet). While VR and AP 
amplitude remained unchanged, the repolarization phase of the AP was significantly 
faster in Gα11 KO cells (Figure 3.5B-D, brown vs. violet). One of the potential reasons 
for this faster repolarization phase appeared to be Itoc up-regulation (~2-fold) in Gα11 KO 
cells (Figure 3.6, brown vs. violet).  
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Figure 3.7:	  The effects of miglyol application on the electrophysiological characteristics of ventricular myocytes from 
wildtype animals. Membrane capacitance (CM), resting membrane potential (VR), and action potential amplitude (AP 
amplitude) (A–C). Number of animals and cells are shown in Supplementary table 1. Error bars represent mean ± 
SEM. The box plots show median (middle band) and 25/75 percentiles (lower/upper quartiles, respectively). 
 
 
Figure 3.8: The effects of miglyol application on the AP duration of ventricular myocytes from wildtype animals. AP 
durations after 30, 50, 70 and 90% repolarization, APD30 (A), APD50 (B), APD70 (C), and APD90 (D), respectively. 
Number of animals and cells are shown in Supplementary table 1. Error bars represent mean ± SEM. 	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Figure 3.9:	  The effects of miglyol application on the electrophysiological characteristics of ventricular myocytes from 
Gα11 KO animals. Membrane capacitance (CM), resting membrane potential (VR), and action potential amplitude (AP 
amplitude) (A–C). Number of animals and cells are shown in Supplementary table 1. Error bars represent mean ± 




Figure 3.10:	  The effects of miglyol application on the AP duration of ventricular myocytes from Gα11 KO animals. AP 
durations after 30, 50, 70 and 90% repolarization, APD30 (A), APD50 (B), APD70 (C), and APD90 (D), respectively. 
Number of animals and cells are shown in Supplementary table 1. The box plots show median (middle band) and 
25/75 percentiles (lower/upper quartiles, respectively). 
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In summary,  
1. Tamoxifen injection resulted in a rather complex, genotype-dependent alteration 
of electrophysiological properties (Itoc up-regulation in wildtype, AP prolongation 
and Itoc down-regulation in Gα11 KO) even though its injection had been 
terminated at least 28 days prior to the actual experiment  
2. Miglyol injection did not modify the electrophysiological properties of ventricular 
myocytes, nor in wildtype neither in Gα11 KO 
3. Gα11 KO resulted in substantial CM reduction, AP shortening and Itoc up-
regulation in ventricular myocytes  
 
3.1.3. Cre recombinase expression causes only minor changes in 
myocyte properties 
Nowadays, Cre/LoxP system is widely used in gene targeting. Improvements in this 
system enabled us to restrict the gene manipulation down to a specific cell type. For 
instance, to generate a cardiomyocyte-specific gene knockout, the Cre expression was 
accomplished under the control of a cardiomyocyte-specific promoter e.g. α-MHC. 
Despite this great power, high levels of Cre expression reported to have toxic effects in 
cardiomyocytes 7. Therefore, we investigated the effects of Cre expression on the AP 
characteristics and Itoc of ventricular myocytes in our Cre/LoxP system. Similar to 
tamoxifen experiments, the effects of Cre expression were studied in wildtype mice and 
mice with Gα11 null-background.  
As shown in figure 3.11 and 3.12 the only electrophysiological parameter that was 
affected by the Cre expression was the magnitude of Itoc in the Gα11-deficient mice 
(Figure 3.12, turquoise vs. violet). Interestingly, this Cre-induced decrease in Itoc did not 
change the APD30 and APD50 (Figure 3.11Db, turquoise vs. violet). It has to be noted 
that the boxes or bars with the same colors as figures 3.5 and 3.6 represent the same 
dataset. 
In summary, Cre expression did not greatly alter the electrophysiological properties of 
ventricular myocytes.  
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Figure 3.11:	  The effects of Cre expression on the electrophysiological characteristics of ventricular myocytes from 
wildtype and Gα11 KO animals. Membrane capacitance (CM), resting membrane potential (VR), and action potential 
amplitude (AP amplitude) (A–C). Representative APs (Da) and action potential durations after 30, 50, 70 and 90% 
repolarization, APD30 and APD50 (Db), APD70 and APD90 (Dc). The boxes or bars with the same colors as figure 3.5 
represent the same dataset. Number of animals and cells are shown in Supplementary table 1. Error bars represent 
mean ± SEM. The box plots show median (middle band) and 25/75 percentiles (lower/upper quartiles, respectively). 
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Figure 3.12:	  The effect of Cre expression on the transient outward current (Itoc) of ventricular myocytes from wildtype 
and Gα11 KO animals. Typical Itoc traces (A), corresponding current-voltage (IV) relationships (B), and the Itoc density 
at +60 mV test potential (C). The boxes or bars with the same colors as figure 3.6 represent the same dataset. 
Number of animals and cells are shown in Supplementary table 1. Error bars represent mean ± SEM. 
 
3.1.4. Two sets of genotypes are sufficient to study the effects of 
Gαq/Gα11 knockout in ventricular myocytes 
I performed two sets of experiments to study the effects of tamoxifen and Cre 
expression on the AP characteristics and Itoc of ventricular myocytes. The results 
showed a modulatory effect of tamoxifen in most of the investigated parameters, which 
was surprisingly dependent on the genetic background (Figure 3.5 and 3.6). In contrast, 
Cre expression did not induce severe changes in most of the electrophysiological 
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parameters (Figure 3.11 and 3.12). Therefore, we concluded that the tamoxifen injection 
on a constant genetic background, similar to what I introduced in figures 3.1 and 3.2, is 
not the best approach to study the effects of Gαq KO. Rather, Cre or loxP insertion 
would better serve this purpose. 
Therefore we designed two genetic approaches to address the role of Gαq; they are 
summarized in tables 3.2 and 3.3. The basic idea behind the set of genotypes 
presented in table 3.2 was to generate Gαq KO by inserting the loxP sites, while table 
3.3 introduces the idea of employing Cre expression. While loxP insertion would require 
the breeding of four separate mouse lines with an increasing genetic distance over time, 
the genotypes introduced in table 3.3 (Cre expression with tamoxifen injection) would 
require the breeding of only two mouse lines, enabling us to compare the Gαq KO 
effects in litter-mates. Therefore, we decided to perform the final set of experiments 
using the genotypes detailed in table 3.3, which all included tamoxifen injection. 
 
Table 3.2: Gαq KO by insertion of LoxP sites. wt, wildtype; tg, transgenic; 0, no Cre expression. 
Label	   gnaq	   gna11	   Cre status 	   Tamoxifen	  
Gqwt G11wt Cre+ Tam+	   wt/wt	   wt/wt	   tg/0	   +	  
Gqfl G11wt Cre+ Tam+	   flox/flox	   wt/wt	   tg/0	   +	  
Gqwt G11- Cre+ Tam+	   wt/wt	   -/-	   tg/0	   +	  
Gqfl G11- Cre+ Tam+	   flox/flox	   -/-	   tg/0	   +	  
 
Table 3.3: Gαq KO by employing Cre expression. wt, wildtype; tg, transgenic; 0, no Cre expression. 
Label	   gnaq	   gna11	   Cre status 	   Tamoxifen	  
 Gqfl G11wt Cre- Tam+	   flox/flox	   wt/wt	   0/0	   +	  
 Gqfl G11wt Cre+ Tam+	   flox/flox	   wt/wt	   tg/0	   +	  
 Gqfl G11- Cre- Tam+	   flox/flox	   -/-	   0/0	   +	  
 Gqfl G11- Cre+ Tam+	   flox/flox	   -/-	   tg/0	   +	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3.1.5. Gαq knockout modifies the electrical properties of 
cardiomyocytes, but its effects depend on Gα11 expression 
Using the genotypes introduced in table 3.3, I studied the impact of Gαq and/or Gα11 KO 
on the AP and Itoc in ventricular myocytes. While Gαq and Gα11 KO alone did not 
significantly change the cell membrane capacitance (Figure 3.13A, blue and green vs. 
black), Gαq/Gα11 DKO resulted in a 15% reduction of CM (Figure 3.13A, red vs. black). 
This CM alteration might be to a great extent due to the Gα11 rather than Gαq KO 
(compare blue & green and blue & red in Figure 3.13A). Gαq KO resulted in a more 
hyperpolarized VR (Figure 3.13B, blue vs. black) and significantly larger AP amplitudes 
(Figure 3.13C, blue vs. black). The AP amplitudes were significantly enhanced in 
Gαq/Gα11 DKO, too (Figure 3.13C, red vs. black) that could be attributed to Gαq KO 
effect rather than Gα11-deficiency (Figure 3.13C, green vs. black and blue vs. black).  
In contrast to most of the alterations of AP shape introduced so far (Fig 3.5 and 3.11), I 
did not find any significant changes in the repolarization phase of AP while investigating 
myocytes from our optimized genotypes (Figure 3.13D), despite significant but minor 
alterations in the Itoc–voltage relationships (Figure 3.14, green vs. red and black). 
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Figure 3.13:	  The effects of Gαq and/or Gα11 KO on the electrophysiological characteristics of ventricular myocytes. 
Membrane capacitance (CM), resting membrane potential (VR), and action potential amplitude (AP amplitude) (A–C). 
Representative APs (Da) and action potential durations after 30, 50, 70 and 90% repolarization, APD30 and APD50 
(Db), APD70 and APD90 (Dc). The boxes or bars with the same colors as figures 3.1 and 3.5 represent the same 
dataset. Number of animals and cells are shown in Supplementary table 1. Error bars represent mean ± SEM. The 
box plots show median (middle band) and 25/75 percentiles (lower/upper quartiles, respectively). 
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Figure 3.14: The effect of Gαq and/or Gα11 KO on the transient outward current (Itoc) in ventricular myocytes. Typical 
Itoc traces (A), corresponding current-voltage (IV) relationships (B), and the Itoc density at +60 mV test potential (C). 
The boxes or bars with the same colors as figures 3.3 and 3.6 represent the same dataset. Number of animals and 
cells are shown in Supplementary table 1. Error bars represent mean ± SEM.  
 
In summary,  
1. Gαq/Gα11 DKO resulted in CM reduction.  
2. Gαq KO resulted in significantly more negative VR.  
3. Gαq KO as well as Gαq/Gα11 DKO resulted in significantly higher AP amplitudes. 
4. The repolarization phase of AP remained unchanged in all genotypes.  
5. Gα11 KO altered the Itoc-voltage relationships. 
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3.2. Hyperaldosteronism-induced electrical remodeling in 
ventricular myocytes of wildtype and Gαq/Gα11 KO mice 
Hyperaldosteronism is a risk factor for cardiac diseases because it induces 
hypertension 220. It was recently reported that aldosterone induces cardiac remodeling 
independent of the effects on the arterial blood pressure 46. Since then many studies 
investigated the physiological and pathological effects of aldosterone on the heart 212. 
Recently our group in a collaborative work with Neuberger group, reported an important 
role for aldosterone in the development of atrial fibrillation 158. In the current study, we 
aimed to investigate the putative role of Gαq/11 coupled signaling pathways in 
aldosterone-induced on the heart. We also studied cellular remodeling process in 
response to hyperaldosteronism.  
To address the possible involvement of Gαq/11 signaling in the aldosterone effects, I 
took the advantage of our four optimized genotypes described in table 3.3. 
Hyperaldosteronism (HA) was induced in mice (see 2.4) and was confirmed by ELISA 
tests indicating a 8-fold increase in the plasma aldosterone level (from 292.5 pg/ml to 
2400 pg/ml). We studied remodeling on the level of the heart as well as on the isolated 
ventricular myocytes. Various morphological and functional properties of the heart were 
assessed using echocardiography. On the cellular level, the electrophysiological 
properties and Ca2+ handling were investigated. In this thesis I will present the results of 
electrophysiological studies. The effects of HA on the AP characteristics and Itoc were 
assessed in ventricular myocytes from Gαq and/or Gα11 KO mice.  
 
3.2.1. Aldosterone effects on CM and VR is mediated by Gαq/Gα11 
proteins  
The sustained increase in the plasma aldosterone level has shown to enhance the risk 
of human left ventricular hypertrophy 212. In a rat model of induced HA, the hypertrophic 
response was associated with larger cardiomyocyte size 186. I also investigated this in 
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the mouse model of induced HA by measuring CM. While chronic HA did not affect CM in 
wildtype cells, Gα11 KO and Gαq/Gα11 DKO resulted in ~  15% HA-mediated decrease of 
the CM (Figure 3.15A, red & green). Since CM remained unchanged in Gαq KO following 
HA (Figure 3.15A, Blue), thus the effects seen in Gαq/Gα11 DKO might be attributed to 
the aldosterone-Gα11 KO interaction.  
The chronic HA induced minor changes on VR. While following HA, VR shifted to more 
negative potentials in wildtype cells, the absence of either Gαq or Gα11 abolished this 
hyperpolarization (Figure 3.15B).  
In summary, 
1- HA resulted in CM reduction in Gα11 and Gαq/Gα11 DKO ventricular myocytes. 
2- HA resulted in more negative VR in wildtype cells and this effect was abolished 







Figure 3.15: The effects of HA on the electrophysiological characteristics of ventricular myocytes. Membrane capacitance (CM), resting membrane potential (VR), and action 
potential amplitude (AP amplitude) and time to peak (TTP) (A–D). Number of animals and cells are shown in Supplementary table 2. The box plots show median (middle 
band) and 25/75 percentiles (lower/upper quartiles, respectively). 
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3.2.2. Cardiac action potential is greatly altered by 
hyperaldosteronism 
Many cardiac diseases are accompanied by cellular electrophysiological remodeling 
that is often manifested in alterations of APs 43. In our study we aimed to investigate the 
putative role of HA in electrophysiological remodeling of cardiac cells and the AP was 
chosen as a parameter integrating many electrical characteristics of the cell. Similar to 
3.2.1, the putative HA-induced alterations of AP were investigated in various genotypes 
to study the contribution of Gαq and Gα11 signaling. 
All AP measurements were performed in steady-state at 4 Hz and 37 ˚C. The 
depolarization phase of the AP was studied by analyzing two important parameters: (i) 
AP amplitude and (ii) time to peak (TTP). The AP amplitude was significantly enhanced 
(~13%) by HA in ventricular myocytes of wildtype mice (Figure 3.15C, black). Similar 
result was obtained in the Gαq-deficient myocytes (Figure 3.15C, blue). In contrast, 
deletion of either Gα11 or Gαq/Gα11 proteins abolished this HA-mediated effect on the 
AP amplitude (Figure 3.15C, green & red, respectively).  
The TTP was not affected by HA in wildtype cells (Figure 3.15D, black). Gαq and/or 
Gα11 KO did not alter this AP parameter, too (Figure 3.15D, green & red). 
HA-induced hypertrophic responses were shown to be associated with AP prolongation 
in cardiac myocytes 18,142. In contrast, I found that APD30, APD50 and APD70 were 
significantly shortened in wildtype cells following HA as reflected in exemplified APs, too 
(Figure 3.16, black). While this effect was completely blunted by either Gαq or Gα11 
protein deletion, removal of both proteins (Gαq/Gα11 DKO) reversed that (Figure 3.16, 
blue, green & red). AP durations were substantially prolonged in ventricular myocytes of 





	   69	  
	  
Figure 3.16: The effect of HA on AP shape of ventricular myocytes.  Representative APs in wildtype, Gαq KO, Gα11 
KO, and Gαq/Gα11 DKO in control (left column) and following HA (right column). Number of animals and cells are 
shown in Supplementary table 2. 
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Figure 3.17: The effects of HA on the AP durations of ventricular myocytes. Representative APs (A) and statistical analysis of AP durations at 30, 50, 70 and 90% 
repolarization, APD30 (B), APD50 (C), APD70 (D), and APD90 (E), respectively. Number of animals and cells are shown in Supplementary table 2. The box plots show median 
(middle band) and 25/75 percentiles (lower/upper quartiles, respectively). 
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In summary, 
1. HA caused larger AP amplitudes in wildtype and Gαq KO cells but no effects in 
cells from Gα11 or Gαq/Gα11 DKO. 
2. HA did not alter time to peak of depolarization phase of AP in all genotypes 
studied. 
3. HA resulted in a shortened AP repolarization when investigating wildtype cells, 
an unchanged AP in single KOs but a prolonged AP repolarization in DKO. 
  
3.2.3. Itoc is the target of aldosterone effects in ventricular myocytes 
In the following, I investigated putative ionic currents contributing to these AP 
alterations. Changes in the Ito density as well as alterations in mRNA expression of 
Kv4.2 and KV4.3 have been attributed to HA 18,46. Thus, I studied Itoc to investigate their 
putative contribution to changes in APD30.  
Itoc was greatly altered in wildtype cells following HA (Figure 3.18A). Interestingly, HA 
caused an increased Itoc density that was absent in single KO animals (Figure 3.18A & 
B & C and 3.19 black, blue and green). Unexpectedly, the density of Itoc was reduced 
following HA in the cells from animals with Gαq/Gα11 DKO (Figure 3.18D and 3.19 red). 
This was in agreement with the behavior of APD30 in these genotypes (Figure 3.17A & 
B, blue and green). While the current-voltage relationships were significantly different in 
Gα11 following HA (Figure 3.18Cb), the Itoc density at +60 mV was not (Figure 3.19, 
green). A possible explanation for this apparent discrepancy could be that the sample 
size at +60 mV might be the limiting factor for statistical analysis. 
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Figure 3.18:	  The effect of HA on the Itoc-voltage relationships. Typical Itoc traces and corresponding current-voltage 
(IV) relationships in wildtype (Aa-b), Gαq KO (Ba-b), Gα11 KO (Ca-b) and Gαq/Gα11 KO (Da-b). Number of animals 
and cells are shown in Supplementary table 2. Error bars represent mean ± SEM.  
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Figure 3.19:	  The effect of HA on the Itoc density in ventricular myocytes. Itoc density at +60 mV test potential. Number 
of animals and cells are shown in Supplementary table 2. Error bars represent mean ± SEM.  
 
In summary : 
1- HA altered the Itoc density and current-voltage relationships in ventricular 
myocytes from wildtype and Gαq/Gα11 DKO mice. 
2- In wildtype cells, Itoc density was enhanced and the Itoc-voltage relationships were 
altered. 
3- In Gαq/Gα11 cells, the Itoc density was decreased and current-voltage 
relationships were modulated. 
4- While HA altered the Itoc-voltage relationship, it did not induce significant changes 
in current densities in Gα11 KO cells. 
5- The results of Itoc measurements were in great agreement with the results of 
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3.3. I1624E mutation in the IQ motif of Cav1.2 and the effects on 
the ICa,L and EC Coupling gain 
In contrast to the skeletal muscle, contraction of cardiomyocyte is majorly dependent on 
the extracellular Ca2+. LVDCCs mediate the Ca2+ influx and provide the initial trigger for 
further Ca2+ release from SR. The LVDCC is regulated precisely to control the 
contractility of cardiomyocyte. One regulatory mechanism that originates from the 
intrinsic properties of the channel is the Ca2+-dependent inactivation (CDI), which is 
mediated by CaM. There are growing body of evidences showing that CaM binds to the 
IQ motif of Cav1.2 which is located at amino acids 1624–1635 77,227,229. Ile-1624 was 
especially characterized as the determinant of CaM binding to Cav1.2 152. Mutation of 
Ile-1624 to Glu (I/E mutation) decreased the affinity of IQ sequence for CaM by ~100-
fold 49 and abolished CDI of ICa,L expressed in Xenopus oocytes 228. However the 
physiological relevance of the IQ motif in the channel regulation has not been clarified in 
the hearts of living animals. To address this question, transgenic I/E mice were 
generated (see 2.3.2). To study the physiological and pathological impacts of I/E 
mutation, the morphological and functional properties of the heart as well as single 
ventricular myocytes were assessed. In this thesis I will present the results of ICa,L and 
EC coupling gain measurements.  
 
3.3.1. Mutation in IQ motif of Cav1.2 modifies the channel function  
To study the physiological relevance of the I/E mutation in the Cav1.2 function and 
regulation, ICa,L was recorded in ventricular myocytes of I/E and control (Ctr) mice (for 
genotypes see 2.3.2). The IV relationships showed a substantial reduction of the current 
density in I/E cells (Figure 3.20 B), which is evident in the representative current traces, 
too (Figure 3.20Aa & Ab). The peak current amplitude was reduced by 33% in I/E cells 
at 0 mV. The I/E mutation did not cause any alterations of the membrane area (CM) 
(Figure 3.21B). Since the Western blot analysis showed reduced Cav1.2 levels in the 
ventricles of I/E mice compared to Ctr mice 152, there might be some alterations of the 
channel assembly due to this mutation. 
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Figure 3.20:	  The effect of I/E mutation on the L-type Ca2+ current (ICa,L) in ventricular myocytes. Typical ICa,L traces in 
control (Ctr) (Aa) and I/E (Ab), and corresponding current-voltage (IV) relationships (B). Number of animals and cells 





Figure 3.21: The effect of I/E mutation on the plasma membrane capacitance (CM). Representative transmission 
images of ventricular cells from Ctr (Aa) and I/E (Ab) mice, scale bar=100 µm. Statistical analysis of CM 
measurements (B). Number of animals and cells are shown in Supplementary table 3. Error bars represent mean ± 
SEM.  
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3.3.2. The I/E mutation results in alterations of EC coupling gain 
EC coupling links the electrical excitation of the cell membrane to the mechanical 
contractile machinery of the cardiomyocyte. ICa,L is a major mediator of this process. 
Since the KO mouse only expressing Cav1.2 I1624E in the heart, displayed a much 
smaller ICa,L but unaltered global Ca2+ transients and single cell contractility 27, I 
wondered whether in a compensatory fashion, the EC coupling gain was altered. To 
study this, I performed simultaneous ICa,L and Ca2+ measurements. Indo-1 was used to 
monitor cellular Ca2+ transients. Briefly, cardiomyocytes were voltage clamped and 
repetitively depolarized (10 times at 0.5 Hz) to obtain steady-state conditions (see 2.9). 
This prepulse was followed by a series of test pulses (from -50 mV to +50 mV with 10 
mV increments) to activate ICa,L. The resulting Ca2+ transients (CICR) were recorded 
simultaneously. Figure 3.22Aa shows the typical bell-shaped Vm dependence of ICa,L 
and the resulting Ca2+ transients. The steady-state ICa,L was reduced over the entire 
voltage range (Figure 3.22Aa). Unexpectedly, under voltage-clamp conditions, the Ca2+ 
transient amplitudes were substantially increased in cells from I/E mice (Figure 3.22Aa), 
which is also evident in the representative Ca2+ signals (Figure 3.22Ad). 
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Figure 3.22: The effects of I/E mutation on EC coupling. Vm-dependencies of ICa,L and global Ca2+ transients (Aa), 
schematic illustration of the protocol used for the measurements (Ab), representative examples for ICa,L (Ac), and 
Ca2+ transients (Ad) in ventricular myocytes from Ctr and I/E mice. Vm-dependence of EC coupling gain calculated 
from the data in Aa (B). Number of animals and cells are shown in Supplementary table 4. Error bars represent mean 
± SEM. 
 
In order to further quantify EC coupling, I calculated the ratio of Ca2+ transient amplitude 
over ICa,L amplitude, the so called EC coupling gain (see 2.9). The results of such an 
analysis are depicted in figure 3.22B and strongly indicated a substantially augmented 
EC coupling gain, particularly for lower membrane potentials. 
Under control conditions, there was a left shift in the voltage-dependence of the whole 
cell Ca2+ transient compared to ICa,L. While the IV relationships for ICa,L peaked at 
around 0 mV, the cellular Ca2+ transients displayed the largest amplitude 10 mV more 
negative, at -10 mV (Figure 3.22Aa). This discrepancy originates from the fact that the 
whole cell ICa,L is the sum of single channel currents (iCa) through thousands of 
individual open channels (ICa = iCa x NP0). On the other hand, individual Ca2+ channels 
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trigger local Ca2+ release events so called Ca2+ sparks from the SR. Thus, locally, the 
Ca2+ release probability to a large degree critically depends on the single channel 
current (iCa) rather than global ICa,L. Due to a large driving force for Ca2+ influx at 
negative membrane voltages, iCa is higher at more negative potentials. As a 
consequence, the probability that iCa could trigger a Ca2+ spark increases at these 
voltages. Therefore the EC Coupling gain is higher at more negative Vm 36,169. 
In the native Ca2+ channel, the IQ motif was reported to be the site for CaM binding and 
this supposed to mediate CDI. The I/E mutation introduced here prevents CaM binding. 
I thus analyzed the inactivation properties of ICa,L in the ventricular myocytes of I/E mice. 
Time constants of ICa,L inactivation (τ1, τ2) were calculated according to the formula 
described in 2.6.4. While τ1 characterizes the fast inactivation, which can be attributed to 
the CDI, τ2 describes the slow component of inactivation resulting from VDI. Both, CDI 
and VDI remained unchanged in I/E mutated cardiomyocytes compared to Ctr cells at 0 
mV test pulse (Figure 3.23A & B). However further studies using Ba2+ as the charge 
carrier showed that the I/E mutation resulted in Ca2+ channels permanently locked in 
CDI 152. Interestingly, although the ICa,L density was decreased in I/E cells, the amount 
of Ca2+ charge (current integral) remained unchanged (Figure 3.23C).  
 
 
Figure 3.23: The effects of I/E mutation on ICa,L inactivation. Time constant of Ca2+-dependent inactivation (τ1) (A), 
time constant of voltage-dependent inactivation (τ2) (B), and the amount of charge entry (∫ ICa,L) (C) at 0 mV. Number 
of animals and cells are shown in Supplementary table 3. Error bars represent mean ± SEM. 
 
In summary, 
1. I/E mutation resulted in enhanced EC coupling gain. 
2. I/E mutation caused the Ca2+ channel to be permanently locked in CDI. 
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3.4. ICa,L and EC coupling gain in the ventricular myocytes 
expressing RacET 
Rac is a small GTPase of the Rho-family and contributes to various cellular functions 
such as transcriptional regulation and cytoskeleton organization in nonmuscle cells 198. 
Increases in Rac expression and activity have been associated with human cardiac 
pathologies such as dilated and ischemic cardiomyopathies 119 as well as atrial 
fibrillation 4. Using an animal model with cardiac specific increases in Rac activity, the 
RacET mouse 184, my group recently described impaired ventricular function 157 
(Oberhoffer, 2012 submitted paper). I thus investigated the relationship between ICa,L 
and Ca2+ release by analyzing the EC coupling gain. 
Since SR Ca2+ release is triggered by Ca2+ influx through LVDCCs, Changes in ICa,L 
might be a substrate for subsequent alterations of Ca2+ handling. ICa,L was measured in 
ventricular myocytes of RacET mice according to the protocol for ICa,L activation 
described in 2.7.4. ICa,L was unchanged in the cells from RacET mice (Figure 3.24Aa & 
Ab), as reflected in the overlapping IV relationships (Figure 3.24B). 
 
 
Figure 3.24: The effect of expression of a constitutively active Rac1 on the L-type Ca2+ current (ICa,L) in ventricular 
myocytes. Typical ICa,L traces in control (Ctr) (Aa) and I/E (Ab), and corresponding current-voltage (IV) relationships 
(B). Number of animals and cells are shown in Supplementary table 4. Error bars represent mean ± SEM. 
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To study EC coupling gain, I performed simultaneous ICa,L and Ca2+ transients 
measurements (see 2.9). Interestingly, the peak steady-state ICa,L was substantially 
reduced in myocytes from RacET mice compared to WT (Figure 3.25 Aa). Despite this 
decrease, the Ca2+ transient amplitude was enhanced by 2.5-fold (Figure 3.25Aa). 
Consequently, the EC coupling gain was significantly enhanced in the ventricular 
myocytes from RacET mice (Figure 3.25B). 
 
	  
Figure 3.25:	  The effect of expression of a constitutively active Rac1 on EC coupling. Vm-dependencies of ICa,L and 
global Ca2+ transients (Aa), schematic illustration of the protocol used for the measurements (Ab), representative 
examples for ICa,L (Ac), and Ca2+ transients (Ad) in ventricular myocytes from WT and RacET mice. Vm-dependence 
of EC coupling gain calculated from the data in Aa (B). Number of animals and cells are shown in Supplementary 
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The inactivation properties of ICa,L were also investigated. τ1 was ~ 1.5 times larger in 
RacET (Figure 3.26A) at 0 mV test pulse, indicating an altered CDI. Since CDI is 
believed to be a local process, one could speculate that the local control of CDI might 
have been altered in RacET myocytes, possibly brought about by an altered Ca2+ 
channel↔ RyR interaction. Despite a significant larger τ1, the time constant of VDI (τ2) 
appeared to be similar in both genotypes (Figure 3.26B). As expected, the amount of 
charge entering the cell by Ca2+ influx at 0 mV test pulse, was significantly reduced in 
RacET (Figure 3.26C). 
 
 
Figure	   3.26:	   The effects of expression of a constitutively active Rac1 on ICa,L inactivation. Time constant of Ca2+-
dependent inactivation (τ1) (A), time constant of voltage-dependent inactivation (τ2) (B), and the amount of charge 
entry (∫ ICa,L) (C) at 0 mV. Number of animals and cells are shown in Supplementary table 4. Error bars represent 
mean ± SEM.	  
 
In summary,  
1. Expression of a constitutively active Rac1 resulted in the reduction of steady-
state ICa,L in ventricular myocytes. 
2. Expression of a constitutively active Rac1 caused higher EC coupling gains. 
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3.5. The effect of CytoD supplement on AP characteristics of 
cultured cardiomyocytes  
Cytochalasin D (CytoD) is a fungal metabolite that inhibits cytokinesis. Cytoskeletal 
microfilaments are the targets of CytoD function. In cardiomyocytes, CytoD is supposed 
to function as a F-actin disruptor 26,35. However, some studies suggested a role for 
CytoD in stabilizing the actin filaments 41,106. These studies showed that CytoD could 
preserve the morphology of cardiomyocytes when used as a culture supplement at 40 
µM. T-tubular disarray/loss accompanies short-term culture of adult ventricular 
myocytes, possibly mediated by cytoskeletal rearrangement 78 and CytoD could blunt 
this process. Since t-tubular disarray is a concomitant process to many cardiac 
diseases such as the development of heart failure, investigations toward the relation 
between cytoskeleton and t-tubular system would be of particular interest. The aim of 
this study was to investigate whether CytoD affects the morphology and function of 
adult cardiomyocytes in culture and whether and how it can be used as a routine 
supplement in primary culture of cardiomyocytes.  
As reported previously 41, we also applied CytoD at the suggested concentration of 40 
µM to our optimized primary culture 78,201 and evaluated its effects on the morphology 
and function of cultured adult rat ventricular myocytes. Recently our group reported that 
a 3-day culturing period was associated with significant t-tubular loss in cardiomyocytes 
78. This was also reflected in a significant reduction of CM (~26%) in control cells at 
DIV3 compared to DIV0 (Figure 3.27, black). As stated before, CM is a measure of 
membrane area. When 40 µM CytoD was used as the culture supplement, CM was 
preserved at DIV3 (Figure 3.27B, red). This finding was in agreement with 
morphological studies of the t-tubular system 191 and indicated that a t-tubular loss was 
absent in the cultures supplemented with 40 µM CytoD. Nevertheless, a detailed study 
of the cells’ plasma membrane system using confocal microscopy revealed significant 
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When analyzing the AP characteristics in naïve cells, I found a significant depolarization 
of VR at DIV3 compared to DIV0 (Figure 3.28A, black). In contrast, application of 40 µM 
CytoD induced VR hyperpolarization during culturing (Figure 3.28A, red). Three days 
culturing did not result in significant changes of the AP amplitude regardless of the 
presence or absence of 40 µM CytoD (Figure 3.28B).  
 
 
Figure 3.28:	   The effects of 40 µM CytoD on the electrophysiological characteristics of cultured adult ventricular 
myocytes. Resting membrane potential (VR), and action potential amplitude (AP amplitude) (A–B) in cultured cells 
with or without 40 µM CytoD supplement. Number of animals and cells are shown in Supplementary table 5. Error 
bars represent mean ± SEM. 	  
Figure 3.27: The effect of 40 µM CytoD on the 
plasma membrane capacitance (CM) of adult 
cultured cardiomyocytes. Representative images 
of cultured ventricular myocytes at DIV0 and DIV3 
with or without CytoD supplement, scale=100 µm 
(A), Analysis of 40 µM CytoD effect on CM (B). 
Number of animals and cells are shown in 
Supplementary table 5. Error bars represent mean 
± SEM.  
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Figure 3.29:	  The effects of 40 µM CytoD on AP duration of cultured adult ventricular myocytes. AP durations after 30, 
50, 70 and 90% repolarization, APD30 (A), APD50 (B), APD70 (C), and APD90 (D), respectively. Number of animals and 
cells are shown in Supplementary table 5. Error bars represent mean ± SEM. 	  
 
Chronic CytoD application at 40 µM, as a culture supplement, resulted in large 
alterations of the AP duration (Figure 3.29A). While at DIV3 AP duration was not altered 
in the absence of CytoD (Figure 3.29A, black), CytoD supplement evoked an AP 
prolongation (Figure 3.29A & B, red). CytoD had a considerable effect on the both early 
and late repolarization, however the impact on the late phase was more prominent. 
While at DIV3, APD30 was prolonged ~2-fold, a 5-fold increase in APD90 was 
observed with 40 µM CytoD in the culture medium (Figure 3.29Ba & Bd, red). Therefore, 
CytoD appeared to have unfavorable effects on the AP properties at this concentration. 
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Figure 3.30: The effect of 0.5 µM CytoD on the 
plasma membrane capacitance (CM) of cultured 
adult cardiomyocytes. Representative images of 
cultured ventricular myocytes at DIV0 and DIV3 with 
or without CytoD supplement, scale=100 µm (A), 
Analysis of 0.5 µM CytoD effect on CM (B). Number 
of animals and cells are shown in Supplementary 
table 6. Error bars represent mean ± SEM.  
	  
We therefore searched for an optimal concentration at which CytoD would preserve 
both, the morphology and function. We performed dose-response experiments and 
investigated the amplitude of electrically induced Ca2+ transients as the readout of initial 
screening (dose-response experiment was performed by Dr. Tian). As a result, 0.5 µM 
CytoD appeared to be the optimal CytoD concentration which best preserved DIV0 
properties at DIV3 191. 
Thereafter, we investigated whether additional important functional characteristics of 
cultured cells were also preserved at this CytoD concentration.  
0.5 µM CytoD had beneficial effect on the morphological properties of the cultured 
cardiomyocytes as indicated by the CM measurements. While CM was significantly 
altered at DIV3 compared to DIV0 (Figure 3.30B, black), 0.5 µM CytoD could diminish 
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0.5 µM CytoD did not display unfavorable effects on VR (Figure 3.31A). Furthermore, 
the AP amplitude was well preserved by application of 0.5 µM CytoD supplement 
(Figure 3.31B). While the AP amplitude showed a 20% decrease at DIV3 in the absence 
of CytoD, 0.5 µM CytoD in the culture medium suppressed this alteration. 
 
	  
Figure 3.31:	   The effects of 0.5 µM CytoD on the electrophysiological characteristics of cultured adult ventricular 
myocytes. Resting membrane potential (VR) (A), and action potential amplitude (AP amplitude) (B) in cultured cells 
with or without 0.5 µM CytoD supplement. Number of animals and cells are shown in Supplementary table 6. Error 
bars represent mean ± SEM.  
 
In addition to beneficial effects on the morphology, this CytoD concentration did not alter 
AP durations (Figure 3.32A & B). 
In summary, 
1. Application of 40 µM CytoD in culture medium resulted in the preservation of CM 
at DIV3, but alteration of electrophysiological properties such as more 
hyperpolarized VR and AP prolongation. 
2. Application of 0.5 µM CytoD in culture medium resulted in the preservation of 
both CM and electrophysiological properties including VR and AP characteristics. 
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Figure 3.32:	  The effects of 0.5 µM CytoD on AP duration of cultured adult ventricular myocytes. AP durations at 30, 
50, 70 and 90% repolarization, APD30 (A), APD50 (B), APD70 (C), and APD90 (D), respectively. Number of animals and 
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4. Discussion 
4.1. Heart-specific inducible Gαq/Gα11 knockout 
Different hormones and neurotransmitters regulate cardiomyocyte’s function by 
activation of intracellular signaling cascades 98. These signaling molecules mainly 
function to maintain or to modulate cellular homeostasis 98. However, chronic 
unbalanced stimulation leads to pathological responses. In the first chapter of my thesis, 
I aimed to investigate the possible contribution of Gαq/11 signaling to the physiology of 
cardiac mocytes. To study the function of a protein in cardiac cells, different 
experimental tools can be employed. In earlier studies, primary culture of cardiac 
myocytes or “myocyte like” cell lines were the most common approaches to accomplish 
this aim 134. However many physiological aspects such as paracrine interactions and 
cellular growth as a chronic response could not be investigated in these two-
dimensional environments (in vitro). Inhibition of a protein was the classical approach 
but often accomplished by blockers lacking proper sensitivity and specificity. Thus, 
protein down-regulation by gene knockout or siRNA have also been employed on the 
cellular level. The generation of transgenic animals was a major step forward since it 
enabled such investigations including cellular signaling. To generate transgenic 
animals, different techniques have been developed and employed over the last 
decades. In the cardiac research field, the power to target gene manipulations to the 
heart was always a desire. The creation of transgenic mice expressing Cre 
recombinase under the control of the α-MHC promoter fulfilled this request 7. The 
further improvements of the Cre/LoxP system using Cre-ER, allowed defined genetic 
alterations in a temporal and tissue-specific manner (Figure 4.1). The most common 
Cre mice (MerCreMer) in cardiac research field was introduced by Sohal and co-
workers 182. However these Cre mice showed cardiac dysfunction such as a decreased 
fractional shortening and increased end diastolic diameter 104,134. Thus, recent 
publications emphasized the necessity for proper controls when using the Cre/LoxP 
technology due to these system-inherent deficiencies 104,134,172. 
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Figure 4.1: Cre-ER/LoxP system. Cre-ER is under the control of a cell type-specific promoter. The Cre mouse is 
crossbred to a mouse carrying the LoxP flanked-target gene. The resulting offspring contains both, the tissue-specific 
promoter-Cre-ER and LoxP flanked-target gene. Cre is only expressed in those cell types in which the promoter is 
active. However Cre is inactive unless tamoxifen (ER agonist) is injected to the mice. Tamoxifen injection activates 
Cre recombinase which leads to the excision of the target gene (i) in a specific cell type and (ii) to a given time. Taken 
from www. ics-mci.fr 
 
In this study, we used a novel Cre mouse 187 to accomplish the heart-specific Gαq KO. 
For temporal control of Cre recombinase activation, we employed tamoxifen injection 
(50 mg/kg body weight, 5 consecutive days). Western blot analysis confirmed the 
functionality of the Cre/LoxP system as the expression of the Gαq protein diminished 
over the time course of 25 days following the 1st tamoxifen injection 143. The literature 
describes a variety of tamoxifen concentrations for Cre activation. Clearly, the lower the 
concentration, the lesser unwanted side effects of tamoxifen are to be expected. Sohal 
and co-workers typically used low tamoxifen doses (20 mg/kg body weight) for long time 
periods 182 and revealed this to be insufficient for gene knockout later 104. Considering 
the fact that 50% of the initial tamoxifen concentration is expelled from the blood within 
around 5 days (t1/2=5 days) (Figure 3.4) 116 we assume that at the end of our waiting 
period of at least 28 days, the tamoxifen concentration is too low to cause any effects. 
Nevertheless, this was addressed in a thorough experimental series. 
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4.1.1. The impact of tamoxifen treatment and Cre recombinase 
expression 
As stated before, a novel Cre mouse was used to knock-down Gαq KO. Gαq KO effects 
have been evaluated on the whole heart as well as on the cellular level. On the cellular 
level, we decided to study two largely integrative cellular phenomena for isolated 
ventricular myocytes i.e. APs and electrically induced global Ca2+ transients. The results 
of the electrophysiological experiments will be discussed here. 
Analysis of the AP parameters revealed significant alterations of the AP amplitude and 
the AP duration in cardiomyocytes from Gαq KO mice (Fig. 3.1). For my experiments I 
initially followed the classic approach, i.e. I compared tamoxifen-injected animals with 
those not injected with tamoxifen. However, when we carefully considered such an 
approach we wondered how valid this might have been. The KO group was different 
from control in two aspects; (i) the desired cardiomyocyte-specific Gαq KO and (ii) the 
unavoidable tamoxifen treatment. Furthermore since we were the first group employing 
this novel Cre mouse line, inherent genomic effects of such a system had to be 
evaluated. Thus, we were wondering whether these two factors i.e. (i) tamoxifen and (ii) 
Cre expression had any inherent effects and whether these could interfere with Gαq-KO 
results.  
Unexpectedly, in those studies I found substantial alterations of the AP characteristics 
(Figure 3.5 and 3.6). In cardiomyocytes, the acute effects of tamoxifen are quite well 
known 57,82. Following acute tamoxifen (3 µM) application, He and co-workers found an 
AP prolongation and significant reduction of K+ currents (Ito, Isus, IK1) in rat ventricular 
myocytes. In addition to the repolarization phase of AP, acute tamoxifen application also 
decreased the maximal rate of depolarization and VR. Moreover, the fast Na+ current 
was depressed in ventricular myocytes exposed to 3 µM tamoxifen 82. In contrast, in 
rabbit ventricular myocytes Liu and colleagues reported unaltered AP, Ito and IK1 
following acute application of tamoxifen (3.3 µM). However, they observed a significant 
reduction of ICa at tamoxifen concentrations greater than 1µM and almost complete 
inhibition at 10 µM 113. Moreover, the major tamoxifen metabolite i.e. 4-
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hydroxytamoxifen (1 µM) diminished the density of Ito, IKur and IK1 when applied acutely 
to mouse ventricular myocytes 56. In my experiments when injected into Gα11 KO mice, 
tamoxifen caused AP prolongation and a substantial reduction of Itoc (Figure 3.5 and 
3.6). Chronic tamoxifen treatment was also reported to modulate various K+ currents in 
mouse ventricular myocytes 57. K+ currents contributing to both the early and the late 
repolarization of the AP (Ito, IKur, Iss, IK1), were increased following 60 days constant 
tamoxifen administration. This effect was genomic and resulted from the alterations of 
K+ channels’ gene expression i.e. higher Kv4.3 (Ito), Kv1.5 (IKur), Kv2.1 (Iss) and Kir2.1 
(IK1) 57. However 60 days tamoxifen treatment does not reflect the usual tamoxifen 
injection regime for inducible KO systems, including our own. The AP alterations 
depicted here resulted from a brief period of tamoxifen administration (5-day injection) 
followed by more than 4 weeks without tamoxifen before recording started. Thus, we 
assume that the tamoxifen concentration was already very low after this time period 
(see Figure 3.4). Moreover, the tamoxifen treatment also caused opposite effects 
depending on the particular genetic background (e.g. APDs in Figure 3.5). When it was 
injected to wildtype mice (GqwtG11wtCre-), the AP and Itoc density remained unchanged 
(Figure 3.5, brown vs. grey). In Gα11 KO it caused alterations that were similar to the 
reported effects of an acute tamoxifen application rather than a chronic one, i.e. AP 
prolongation (Figure 3.5, violet vs. green) and Itoc reduction (Figure 3.6, violet vs. 
green).  
Although tamoxifen treatment altered the electrophysiological properties of cardiac cells, 
its application is mandatory to induce Gαq KO when using the Cre/LoxP system. 
However other methods including primary culture of cardiomyocytes have been majorly 
advanced 78,201. Nevertheless, transgenic animals enable us to study protein functions 
in the context of the whole animal. Especially, research on the cardiac pathology 
benefitted from these improvements since they can often not be modeled in culture 134. 
Raloxifen was also proposed as an alternative for tamoxifen in inducible Cre/LoxP 
systems, however raloxifen had to be applied three times longer than tamoxifen to 
achieve similar Cre activity 104. Thus we decided to use tamoxifen for the activation of 
the Cre recombinase. Tamoxifen was administered to every group including our 
controls. Instead we used another determinant for gene KO. 
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Today, the Cre/LoxP system has been extended to perform tissue-, sometimes even 
cell type-specific gene excision. To generate a cardiac-specific gene knockout, the Cre 
expression was restricted under the control of a cardiomyocyte-specific promoter, α-
MHC. However, high levels of α-MHC mediated Cre expression have been reported to 
cause a lethal cardiomyopathy between 8 and 12 months of age 134. Moreover, 
Koitabashi and co-workers found a severe transient dilated cardiomyopathy in the 
tamoxifen-inducible MerCreMer* mouse line even without loxP transgenes 104. Despite 
the great alterations of cardiac function in the MerCreMer mice, in our novel Cre mouse 
line the cardiomyocyte characteristics including electrophysiology were not altered 
greatly (Figure 3.11 and 3.12), thus eliminating the need for additional controls. 
 
4.1.2. The optimized genetic combinations to study Gαq knockout 
In studies using tamoxifen inducible Cre/LoxP system, controls are normally chosen 
from the same genetic backgrounds but not injected with tamoxifen (Figure 3.1 and 3.3). 
However, we believe that it is necessary to include tamoxifen injection in control groups 
as well for any possible genomic interventions. Therefore, we decided not to follow the 
conventional approach of comparing animals in which KO was primarily induced by 
tamoxifen injection (Tamoxifen vs. miglyol/-). But instead we employed a different 
molecular determinant (Cre recombinase) for the induction of KO while maintaining the 
tamoxifen injections in all genotypes. We suggested two sets of genetic combinations 
that could provide us with the required transgenic animals for investigating Gαq and 
Gα11 function (Table 3.2 and 3.3). 
Both approaches followed different strategies to knockout Gαq. The gene excision could 
either be dependent on the presence of Cre recombinase (Table 3.3) or on the 
presence of the LoxP sites in the gnaq gene (Table 3.2), while always maintaining the 
tamoxifen injections. We chose the genetic combinations introduced in table 3.3 in 
which Cre expression is the molecular determinant for Gαq KO. While generation of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Cre flanked by two mutant estrogen receptor ligand-binding domains 
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animals described in table 3.2 would have required breeding of 4 separate mouse lines, 
using Cre expression as the determinant for the KO required only breeding of 2 
separate mouse lines and most importantly allowed us to utilize litter-mates (black vs. 
blue and red vs. green, Table 3.3). Moreover, breeding of 4 separate mouse lines would 
increase the genetic distance which might results in unfavorable genetic differences. 
Using the genetic combinations shown in table 3.3, we generated 4 optimized 
genotypes to address our initial question about the physiological importance of basic 
Gαq/11 signaling (Figure 3.13 and 3.14). 
 
4.1.3. Physiological relevance of Gαq in ventricular myocytes 
The pathological role of Gαq/11 signaling has been extensively studied in the heart. 
These studies benefitted from various kinds of Gαq gene knock-out and knock-in 
10,44,163,211. To date, there is a general agreement about the contribution of Gαq/11 
signaling to the development of hypertrophy; Gαq/Gα11 KO can decrease a hypertrophic 
response 10,211. In general, the hypertrophic responses are accompanied not only by 
structural and electrophysiological remodeling of the cardiac tissue but also by structural 
remodeling of individual myocytes. In electrophysiological experiments, the plasma 
membrane structure of the myocytes can be assessed by determining the plasma 
membrane capacitance. In Gαq/Gα11 KO, the substantial reduction of CM (Figure 3.13A, 
red) might suggest alterations of gene expression and/or the t-tubular disarray. Although 
we did not investigate this further, Gαq/11 signaling pathway is known to be involved in 
cell growth responses 83. 
Another finding was unexpected increase of CM in Gαq KO (Figure 3.13A, blue). While 
deletion of both Gαq and Gα11 caused substantial reduction of membrane capacitance, 
Gαq single KO showed opposite effect. These results suggest that the relationship 
between Gαq and Gα11 is not only compensatory behavior but they might have much 
more complex interrelations.  
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Different intracellular signaling cascades modulate the expression and regulation of 
cardiac ion channels. IK(ATP) and ICa,L for instance are known to be regulated by G-
protein-coupled signaling cascades 185. The PKA-mediated phosphorylation of Cav1.2 
downstream of Gαs activation regulates the channel function. Since the AP is the 
product of multiple ionic currents, its properties are modulated by many intracellular 
signaling cascades. The effect of Gαq signaling on the cardiac AP is not very well 
studied. While Gαq overexpression resulted in markedly prolonged APs 131, the 
knockout of this protein diminished this effect (Figure 3.13Db, blue). Thus, Gαq signaling 
might be important in the regulation of the AP properties and more precisely its 
underlying repolarizing currents such as different IK. Wagner and his co-workers 
showed that Gα11 signaling has a tonic inhibitory effect on Ito which results from 
alterations in the expression of the Kv4.2 protein 202. Moreover, calcinuerin/NFAT 
signaling which is an important regulator of Ito, is activated downstream to Gαq/11 
signaling 83,146,153.  
The membrane potential results from different concentrations and conductances of ions 
across the plasma membrane. In cardiac cells IK1 contributes to the physiological resting 
potential 188. The changes of VR seen in cardiomyocytes from Gαq KO mice might be 
due to alterations of the inwardly rectifying K+ current (IK1) either by changing its 
expression or function. Regulation of IK1 by Gαq was suggested previously 131,193. 
In addition to Gαq, my experiments (Figure 3.5 and 3.6) strongly suggest a role of Gα11 
in regulating K+ currents. In Gα11 KO animals, I observed a large reduction of the AP 
duration and a concomitant augmentation of Itoc. 
How do Gαq and Gα11 proteins mediate changes in gene expression resulting in the 
alterations of electrophysiological characteristics? We believe that the changes were not 
induced by the proteins per se, but instead, our results strongly indicate the importance 
of a constant, possibly low-level stimulation of the upstream G-protein coupled 
receptors with agonists such as endothelin-1 or angiotensin-II 270. When stimulated 
chronically at high levels, G-proteins contribute to the development of cardiac diseases 
and associated changes in gene expression 52,74. In contrast, with sustained stimulation 
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at a much lower hormone level, Gαq and Gα11-coupled signaling pathways appear to be 
important in the maintenance of the myocyte’s homeostasis. 
We thus conclude that both Gαq and Gα11 are instrumental to the physiological 
properties of cardiac myocytes by mediating the continuance of a basic rate of gene 
expression.  
Further studies on the effects of Gαq/11 signaling in gene expression and regulation of 
K+ channels that contribute to the cardiac AP would answer a lot of remaining 
questions. Particularly, the regulatory function of Gαq and/or Gα11 on Ito would help to 
understand the alterations of early repolarization. Moreover, detailed studies on the 
downstream molecules of Gαq/11 signaling such as PLCβ, PIP2, DAG and IP3 are 
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4.2. The relationship between aldosterone and Gαq/11 signaling in 
cardiac pathology 
The renin-angiotensin-aldosterone system’s (RAAS) primary function is to maintain 
homeostasis in response to stress such as a drop in blood pressure 72. Activation of 
RAAS results in retention of the intravascular volume and thus blood pressure. In 
contrast to its protective effects in acute stress responses, chronic stimulation of RAAS 
leads to deleterious effects on the cardiovascular system such as sustained 
hypertension. Hypertension in turn increases the cardiac workload which leads to the 
development of hypertrophy and heart failure 87. The role of aldosterone in 
hypertension-induced cardiac injury is well established. However, recent findings 
showed that aldosterone increases the risk of cardiac diseases independent of 
hypertension 212. Various experimental approaches were employed to investigate the 
direct effect of aldosterone on the heart as well as single cardiomyocytes 63,147,155. On 
the cellular level, one of the major goals was to find the second messengers mediating 
the aldosterone function. In cardiomyocytes, Gαq/11 signaling is one of the intracellular 
cascades that mediates the effects of many hormonal agonists. The genomic effects of 
Gαq/11 signaling are known to be involved to the development of cardiac diseases such 
as hypertrophy and heart failure 83. While both, aldosterone excess and high chronic 
stimulation of Gαq/11 signaling, result in pathological responses of the heart, we were 
wondering whether they are somehow connected. Therefore, we induced 
hyperaldosteronism (see 2.4) in our 4 optimized genotypes (Table 3.3) and studied the 
possible contribution of the Gαq/11 signaling in the aldosterone-mediated cardiac effects. 
In vivo studies showed significantly larger LVID* in aldosterone-treated Gαq/Gα11 DKO 
at both systole and diastole. Moreover, the LV mass† and volume appeared to be 
significantly higher in these animals (studies on the heart were done by Ms. Kathrina 
Wiesen). Single cell measurements showed substantial alterations of AP characteristics 
and Ca2+ handling in both wildtype and Gαq/Gα11 DKO mice following HA. In particular, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Left ventricular inner diameter 
† left ventricular mass 
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HA caused significant reduction of the AP duration in wildtype mice, while the AP 
duration was unexpectedly increased when both, Gαq and Gα11 were knocked out 
(Figure 3.17). In the following I will discuss the results of my electrophysiological 
measurements in ventricular myocytes from wildtype and transgenic mice following HA.  
 
4.2.1. The effect of hyperaldosteronism on CM and VR 
Patients with primary hyperaldosteronism, a condition caused by overproduction of 
aldosterone in the adrenal gland, develop left ventricular hypertrophy 212. As explained 
before, the hypertrophic response can also be studied by evaluating the structural 
remodeling of cardiac cells. I observed a significant CM reduction in Gα11- and Gαq/Gα11 
KO following HA, which might suggest an interference of Gαq/11 signaling with HA-
mediated genomic effects (Fig. 3.15A).  
VR was decreased in wildtype mice following HA (Figure 3.15B, black). Dartsch and co-
workers found a significant down-regulation of mRNA levels for Kir2.1 and Kir2.3 
following a 4-week aldosterone administration using osmotic mini-pumps (1 µg/h) 46. 
Thus, the more hyperpolarized VR in wiltype mice following HA (Figure 3.15B black) 
might have resulted from the altered expression and/or current properties of K1 
channels. Interestingly, the knockout of Gαq and/or Gα11 diminished the aldosterone 
effect on VR (Figure 3.15B, black). This result might be another evidence for the 
contribution of Gαq/11 signaling to HA-mediated genomic effects. 
 
4.2.2. The role of Gαq/11 signaling in HA-induced AP alterations 
HA-mediated cellular electrophysiological remodeling has been reported in atria 158 and 
ventricles 142 of small rodents. I also observed HA-mediated alterations of AP 
characteristics in mouse ventricular myocytes (Figure 3.15 and 3.17, black). In HA, AP 
amplitudes were markedly increased in ventricular myocytes from wildtype mice (Figure 
3.15C, black). Boixel and co-workers found a substantial increase of INa in mouse 
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ventricular myocytes incubated with 1 µM aldosterone for 24 h. However, they did not 
find any alterations in the protein level of Nav1.5 29. We suggest that the larger AP 
amplitudes in wildtype mice following HA, are due to alterations in gene expression or 
function of the Na+ channels. Interestingly, Gα11 KO or Gαq/Gα11 DKO diminished the 
HA evoked changes of the AP amplitude (Figure 3.15C, green & red).  
While Benitah and co-workers showed AP prolongation in aldosterone-treated 
ventricular myocytes 18, I found a substantial reduction of AP duration in the ventricular 
cells from wildtype mice (Figure 3.17, black). However, this controversy might be to a 
large extent due to different experimental settings. While in the former study they 
incubated rat ventricular myocytes with aldosterone for 48 h 18, we used chronic (42 
days) HA in mice (see 2.4). We believe that 42 days are long enough for proliferating 
(genomic) effects of aldosterone. In another study by Ouvrard-Pascaud and co-workers, 
HA was mimicked in a mouse model by overexpression of the hMR* in the heart. They 
observed substantial prolongation of the repolarization phase of the AP in ventricular 
myocytes overexpressing hMR 142. Although our results were not in agreement with this 
AP prolongation, they might suggest different genomic effects induced through other 
intracellular signaling pathways. 
Aldosterone has been shown to modulate the expression and function of various 
cardiac ion channels 18,19,46,147, which might contribute to the AP alterations. Two 
important repolarizing currents, Ito and ICa,L, were shown to be altered by aldosterone 
18,19,147. ICa,L up-regulation and AP prolongation were found in ventricular myocytes from 
transgenic mice with renal salt loss resulting in HA 147. Ito down-regulation has been 
attributed to the genomic effects of aldosterone in cardiac cells 18. However, my results 
of Itoc measurements did not reproduce those findings; they were in good agreement 
with alterations of the early phase of AP repolarization (Figure 3.18).  
Unexpectedly, deletion of Gαq and Gα11 proteins in the heart resulted in AP 
prolongation and Itoc down-regulation following HA (Figure 3.16 and 3.17, red). Both 
effects were opposite to the aldosterone-mediated effects on AP and Itoc seen in 
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wildtype mice. Considering these results, we suggest that Gαq/11 signaling might 
contribute to HA-mediated genomic effects in cardiomyocytes. 
There is a growing body of evidence showing that the pathological effects of 
aldosterone on the heart are indeed independent of changes in blood pressure 212. 
Although, MR and 11β-hydroxysteroid dehydrogenase have been characterized in 
cardiomyocytes 100,114,179, the cellular mediators of the aldosterone effects remained 
unexplored. In the present study, the aldosterone-induced alterations of AP and Itoc 
were described. However, further experiments are crucial to resolve the underlying 
reasons for this AP alterations such as INa, ICa,L and IK measurements. Moreover, 
additional analysis of gene expression of ion channels would help to better interpret the 
results. Furthermore, the intracellular second messengers mediating these aldosterone 
effects should be explored. Our findings support the likelihood for contribution of Gαq/11 
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4.3. Mutation in the IQ motif of Cav1.2 and the impact on EC 
coupling gain 
The contraction of cardiomyocytes is majorly dependent on Ca2+ influx through voltage-
gated Ca2+ channels 23. These channels are regulated by different mechanisms among 
which CDI and VDI are well studied 75,97,109. These regulatory mechanisms require the 
contribution of several molecules that are mainly associated with Cav1.2 15,45. Among 
these molecules, Calmodulin (CaM) is permanently bound to Cav1.2 and functions as a 
Ca2+ sensor 135,149. Ca2+-saturated CaM contributes to the fast CDI 77. It has been 
shown that the IQ sequence in the C-terminal cytoplasmic tail of Cav1.2 (amino acids 
1624-1635) is the major binding site for CaM 77,148. Mutations in the IQ motif inhibited 
CaM binding to the Cav1.2, thus diminished CDI 228. Amino acid exchange in the IQ 
motif (Ilu-1624 with Glu; I/E mutation) resulted in 100-fold reduction of the CaM binding 
affinity and subsequent alteration of CDI in the Xenopus oocyte expression system 228. 
However, the impact of mutations of the IQ motif on the Cav1.2 function in in vivo 
situations remained to be explored. 
 
4.3.1. Generation of the murine cardiac Cav1.2I1624E 
To study the relationship between CaM and IQ motif and the possible role in the 
regulation of Cav1.2, the I/E mutation was primarily generated in a heterologous 
expression system (Xenopus oocyte) and resulted in the alteration of CDI 228. But what 
happens if this mutation is in the cardiac cells and the in vivo situation?  
To address this question, Ile-1624 was exchanged with Glu in the murine cardiac 
Cav1.2 152. Homozygous mice (Cav1.2I1624E/I1624E) were not viable. Therefore, 
Heterozygous Cav1.2+/I1624E mice were crossbred with Cav1.2flox/flox and MerCreMer 
176,182 to generate the basic genotype (Cav1.2flox/I1624E x MerCreMer) to study the I/E 
mutation (see 2.3.2). The excision of the floxed gene (Cav1.2-/I1624E) was induced by 
daily injections of tamoxifen at 4 consecutive days. Although this approach was 
successful, the I/E mice had a reduced life span and died within 3 weeks after the first 
tamoxifen injection (Figure 4.2).  
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Figure 4.2: Survival curve of I/E and Ctr mice. T=0 reflects the start of tamoxifen injection. The survival rate of I/E 
mice reduced to 0% within 3 weeks after tamoxifen injection. Taken from Poomvanicha et al, 2011 134  
 
Different morphological and functional properties of the whole heart as well as single 
cardiomyocytes were assessed. The hearts from I/E mice showed markedly reduced 
fractional shortening and developed a phenotype similar to dilated cardiomyopathy 152. 
Single cell measurements displayed a significant reduction of ICa,L in I/E mice (Figure 
3.20). Despite ICa,L attenuation, global Ca2+ transients and cellular contractility remained 
unchanged 27. To find out the reasons for this contradiction, I studied the coupling 
efficiency of ICa,L and Ca2+ release in single cardiomyocytes and revealed an enhanced 
EC coupling gain in I/E mice (Figure 3.22C).  
 
4.3.2. The impact of I/E mutation on the ICa,L 
The IQ motif is supposed to contribute in Cav1.2 inactivation, but also resulted in a 
significant reduced ICa,L density (Figure 3.20). Since CaM binding to Cav1.2 is disrupted 
by the I/E mutation, we assume that this interference might reduce trafficking of the 
channel to the membrane during biosynthesis and thus diminishes ICa,L, as shown for 
cultured neurons 203. Western blot analysis showed significantly lower Cav1.2 protein in 
the hearts of I/E mice 27. Thus ICa down-regulation was not only caused by a change in 
channel kinetic per se, but also by reduced expression of the Cav1.2I1624E.  
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Cardiac dysfunction results in various adaptive responses such as the stimulation of the 
sympathetic or the renin-angiotensin system leading to the activation of several different 
intracellular signaling molecules including CaMK-II 83. A recent publication suggested a 
suppressive role for CaMK-II on cardiac Cav1.2 gene transcription 164. CaMK-II 
phosphorylation was increased in the myocytes carrying I/E mutation 27, which might 
itself regulate the transcription of Cav1.2 gene, leading to ICa,L down-regulation. 
 
4.3.3. The impact of the I/E mutation on global Ca2+ transients 
Although ICa,L is the primary trigger for SR Ca2+ release, it is not the only determinant of 
the EC Coupling gain. In line with this, the I1624E mutation enhanced the gain of Ca2+ 
release despite a ICa,L reduction. This finding strongly suggests an altered EC coupling 
(Figure 3.22C). EC coupling is mainly dependent on the amplitude and kinetics of the 
Ca2+ signal in the dyadic space 107. Besides the Cav1.2 channel, the RyR2 and the NCX 
all contribute to the Ca2+ signal in this microdomain. While there is no direct data on the 
[Ca2+]i in these domains, a recent paper by Assai and colleagues estimated that during 
EC coupling, Ca2+ in the dyadic space might increase to 10-15 µM within miliseconds 3. 
Nevertheless, our results from simultaneous ICa,L and Ca2+ transient measurements 
suggested significant alterations of signaling in this coupling space (Figure 3.22A).  
My results showed significantly higher EC coupling gain in I/E mice (Figure 3.22C). 
What could be the reason for such a high gain in these cardiomyocytes? Presumably 
the inadequate cardiac performance in I/E mice stimulates the neuroendocrine system. 
β-AR stimulation is one of the major mechanisms to initially compensate such cardiac 
dysfunctions. However, high-level chronic stimulation causes cardiac insults and results 
in cardiac diseases. Activation of PKA downstream to β-AR initiates a wave of 
phosphorylation including the RyR2. PKA was shown to phosphorylate Ser2809 214,215 
which augments the RyR2 function via two mechanisms; (i) increase in the open 
probability of the channel and (ii) decrease in the binding affinity of a channel inhibitor, 
calstabin2. Furthermore, Marks and co-workers showed that phosphorylation of RYR2 
by PKA results in the dissociation of FKBP12.6 from the channel 124. This uncoupling in 
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turn enhances the single-channel open probability. Valdivia et al. showed that PKA 
phosphorylation increases the RyR2 sensitivity to Ca2+ 197. Thus, the phosphorylation 
enhances Ca2+ release activity of the channel in response to a rapid increase of local 
Ca2+, as may be expected near L-type Ca2+ channels 206. Therefore, neurohormonal 
stimulation increases the RyR2 activity resulting in an enhanced EC coupling gain.  
CaMK-II is another regulatory protein of RyR2. CaMK-II phosphorylation modulates the 
channel gating in a way that a given Ca2+ transient can be induced by smaller ICa,L influx 
111,224. CaMK-II can be activated downstream to angiotensin/Gαq signaling, which in turn 
results in the phosphorylation of RyR2 and the sensitization of EC coupling 206. CaMK-II 
phosphorylation increased in the myocytes carrying I/E mutation 27. 
Moreover, Blaich and co-workers showed a substantial reduction of NCX activity in 
cardiomycytes from I/E mice 27, which might in turn increase dyadic Ca2+ signals and 
EC coupling gain.  
In conclusion, we suggest that the I/E mutation leads to cardiac dysfunction by reducing 
ICa,L and subsequent intracellular Ca2+ transients. This cardiac dysfunction initiates a 
series of compensatory responses including neurohormonal stimulation to maintain 
cardiac function. Neurohormonal stimulation increases the EC coupling efficiency by 
modulating the RyR2 phosphorylation, which helps to preserve the myocyte contractility. 
The chronic high-level neurohormonal stimulation as well as sustained [Ca2+]i increase 
stimulates signaling molecules which contribute to genomic responses. These genomic 
effects include cell growth and apoptotic responses that push the cardiac cell in a 
vicious cycle and quickly resulted in dilated cardiomyopathy and death (Figure 4.3). 
 
	  
Figure 4.3: Schematic illustration of I/E mutation effects in the heart. For detailed explanation see 4.3.3. 
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Further studies on the stimulatory hormones such as norepinephrine or angiotensin-II 
would help to better understand the development of cardiac dysfunction in the I/E mice. 
One necessary step would be the evaluation of plasma level of these hormones. 
Moreover, further investigations on the expression and/or regulation of SR Ca2+ release 
channels (including RyR and IP3-R), on the expression of actin and myosin, on the Ca2+ 
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4.4. EC coupling gain in cardiomyocytes expressing RacET 
Rac1 has been proposed to play an important role in the cardiac pathological responses 
by increasing ROS production 119,171. Cardiomyocytes from DCM* patients showed 
higher levels of ROS production associated with increased Rac1 activity 119. Transgenic 
mice expressing cardiac-specific constitutively active Rac1 (RacET) developed transient 
hypertrophy in the early postnatal stage, which diminished a few weeks after birth 184. 
Atrial arrhythmias have been also reported in RacET mice 158. Previously, our group 
studied the hearts of RacET mice and showed a markedly reduced fractional 
shortening. Accordingly, a decrease in cellular contractility along with alterations of 
cellular Ca2+ handling was found in ventricular myocytes expressing RacET (Oberhofer 
et al., submitted manuscript). Because there appeared to be no effect of Rac1 on the 
functional properties of different molecules contributing to Ca2+ handling such as 
SERCA and NCX (Oberhofer et al., submitted manuscript), we were wondering whether 
EC coupling was altered. Therefore, EC coupling gain was assessed and showed 
substantially higher gains in RacET mice (Figure 3.25C).  
RyR2 is one of the well-known redox-sensitive ion channels in the heart. ROS 
modulates the RyR2 sensitivity to Ca2+, thus influencing SR Ca2+ release 225. Moreover, 
ROS has been shown to activate CaMK-II in cardiac myocytes 86, which in turn 
phosphorylates RyR2 and enhances SR Ca2+ release. Therefore Rac1 might increase 
SR Ca2+ release by activating ROS production.  
The pore-forming subunit (α1c) of the cardiac L-type Ca2+ channel contains more than 
10 cystein residues 129, which can be potentially subjected to redox modification. I found 
a significant decrease in steady-state Ca2+ current of RacET mice (Figure 3.25A), which 
was in agreement with a previous report by Goldhaber showing ROS-mediated ICa,L 
down-regulation 71.  
In addition to ROS production, Rac1 mediates the cytoskeletal reorganization at focal 
adhesion sites 184. Our group showed t-tubular loss in the ventricular myocytes 
expressing RacET (Oberhofer et al., submitted manuscript) that could be linked to the 
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alterations of cytoskeletal organization. The t-tubular disarray might lead to the 
impairment of EC coupling and subsequent reduction of cardiomyocyte’s contractility. 
The resulting cardiac dysfunction initiates a series of compensatory responses including 
neurohormonal stimulation to maintain cardiac function. As stated in 4.3.3, activation of 
cellular signaling cascades in response to neurohormonal stimulation leads to an 
increase in SR Ca2+ release and thus higher EC coupling gains. 
Moreover, CDI of ICa,L was prolonged in ventricular myocytes expressing RacET (Figure 
3.26). Since CDI is believed to be a local process, we speculate that the local control of 
CDI might have been altered possibly by an altered Ca2+ channel-RyR interaction. This 
impaired coupling most probably resulted from the effects of Rac1 on the cytoskeletal 
reorganization and t-tubular loss. 
Further studies on the expression and regulation of Cav1.2 and RyR are necessary to 
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4.5. Cytochalasin D as a culture supplement 
The potential to culture cardiac cells is extremely important since the process of 
remodeling starts within a few hours in isolated adult cardiomyocytes. However, various 
biological studies such as expression of exogenous proteins by adenoviral gene transfer 
are critically dependent on maintaining cardiomyocytes in culture for days 102,171. 
Cardiomyocytes undergo profound alterations during long-term culture. Such alterations 
resulted in 50-70% reduction of cell density during the first week of culture 54,175. Among 
morphological and functional changes identified; internalization of intercalated discs 91, 
decreased t-tubular density 132, altered calcium handling 150 and reduced contractility as 
well as decreased VR and ICa,L 58,106, were reported in the cultured adult rat 
cardiomyocytes. Therefore, several groups tried to design culture conditions in which 
cardiomyocyte’s phenotype and function are preserved 78,201. To improve culture 
conditions, we took the advantage of a substance called CytoD, which was reported to 
be useful for long-term culture of adult cardiac myocytes 41,106. To verify the efficiency of 
this substance, we performed a general screening of cardiomyocyte’s morphology and 
functional properties over long-term culture. As a part of the functional studies, I 
investigated the electrophysiological properties of cardiomyocytes over 3-day culture. 
Application of 40 µM CytoD supplement in culture medium resulted in preservation of 
the morphology, whereas AP characteristics were greatly altered during the culturing 
period. In contrast 0.5 µM CytoD could preserve both structure and function including 
AP characteristics. 
 
4.5.1. CM was reduced in long-term culture  
Several studies showed that cardiomyocytes undergo t-tubular loss over long-term 
culture 106,118,132,201. We also assessed the cardiomyocyte’s morphology using different 
approaches. In one approach the plasma membrane was stained using di-8-ANNEPS, 
which allowed visualizing t-tubular loss after 3 days culture 191. Furthermore, CM was 
also evaluated as a part of these studies since it provides information about plasma 
membrane area including both surface membrane and t-tubular system. The results of 
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CM reduction were in great agreement with the membrane staining and provided 
additional independent support for t-tubular loss (Figure 3.27 and 3.30, black). 
Cardiac t-tubules are regulated by different mechanisms: (i) special proteins such as 
Bin1 84 have been suggested to mediate t-tubular formation and ion channel 
organization in these membrane invaginations (ii) biomechanically sensitive regulatory 
proteins (e.g. JP-1/2) induce appropriate t-tubule/SR interaction 199. 
All kinds of these regulatory molecules might be influenced by long-term culture 
resulting in observed t-tubular loss and CM reduction. 
 
4.5.2. Preservation of AP shape in long-term culture 
The idea to use CytoD came from studies indicating beneficial effects of this substance 
in preserving cardiomyocytes’ morphology 41,106. The reported concentration of 40 µM 
appeared to diminish t-tubular loss in cultured cells that was also reflected in the CM 
measurements (Figure 3.27B).  
While previous studies focused on the t-tubular preservation, in the present study 
different functional properties of the cultured cells were also investigated. Besides 
improvements in the morphological properties, APs were significantly prolonged after 3 
days culture with 40 µM CytoD supplement (Figure 3.29). Moreover, further 
investigation of t-tubular structure showed alterations of the t-tubular arrangement after 
3 days culturing with 40 µM CytoD supplement, a phenomena called “t-tubular 
crowding” 191. Therefore, we decided to explore the potential of CytoD as a culture 
supplement by performing a dose-response assay. We employed an important 
physiological parameter i.e. the amplitude of electrically evoked Ca2+ transients, as the 
readout in these experiments. We found that with respect to global Ca2+ transients 
CytoD at sub-micromolar concentrations (0.5 µM) preserve DIV0 conditions at DIV3 
extremely well 191. 
To further investigate the beneficial effect of the 0.5 µM CytoD supplement on functional 
properties of myocytes, APs were recorded in cultured cardiomyocytes. The AP shape 
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remained unchanged after 3 days in culture with 0.5 µM CytoD (Figure 3.32) together 
with morphological preservation (Figure 3.30, white). Therefore, AP recordings provided 
additional support for 0.5 µM CytoD as an appropriate culture supplement. 
The effects of CytoD on cardiac AP and ion currents are rather unexplored. There are a 
few reports studying the acute effects of CytoD on cardiac ion currents 126,196. 
Undrovinas et al. showed a significant reduction of INa after acute application of 20-40 
µM CytoD 196. CytoD (10 µM) was shown to influence the gating of inwardly rectifying K+ 
channels 126. Alterations in both Na+ and K+ currents would induce changes in the 
amplitude and shape of APs. However we did not find any changes in the shape of APs 
in the presence of 0.5 µM CytoD, but our results can not be compared with previous 
reports of acute CytoD application. Since in our experiments CytoD was only present in 
the culture medium and washed out prior to the experiments. If there had been changes 
of the AP in the presence of CytoD, this effect would have been diminished immediately 
after washout. Furthermore, the discrepancy between our results and previous findings 
can be explained by different concentrations of CytoD used for each study. While 
previous studies mainly used 10 to 80 µM CytoD 126,196 our primary culture benefitted 
from 0.5 µM CytoD supplement. 
Taken together, we conclude that 0.5 µM is the optimal concentration to maximally 
preserve cellular electrophysiology over a culture period of 3 days. This time is sufficient 
for the expression of fusion proteins and genetically encoded biosensors 78,93,201. 
Therefore primary culture of cardiomyocytes with 0.5 µM CytoD supplement can be 
used as an advanced cellular model for genetic as well as pharmacological 
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Supplementary table 1: The electrophysiological results of transgenic mice used in 3.1. In the first row of each genotype 
either the results are shown as median with corresponding 25/75 percentiles or as mean ± SEM. In the second row the first 
number shows the animal number, the second number shows the amount of cells. 
 





(ms) APD50 (ms) APD70 (ms) APD90 (ms) Itoc (pA/pF) 
Gqfl G11- Cre+ Tam- 
145.4 








(6.4/15.2) 23.8 ± 2.6 
(3/22) (3/16) (3/16) (3/16) (3/16) (3/16) (3/16) (3/20) 
Gqfl G11- Cre+ Tam+ 
128.2 








(8.8/53.6) 16.6 ± 2.2 
(5/45) (5/31) (5/31) (5/31) (5/31) (5/31) (5/31) (5/24) 
Gqwt G11wt Cre- Tam- 
177.1 








(12.9/43.1) 19.3 ± 2.0 
(4/33) (4/28) (4/27) (4/27) (4/27) (4/27) (4/27) (4/23) 
Gqwt G11wt Cre- Tam+ 
195.0 








(10.2/58.5) 25.0 ± 3.5 
(3/25) (3/21) (3/19) (3/19) (3/19) (3/19) (3/19) (3/20) 
Gqfl G11- Cre- Tam- 
128.3 








(5.2/7.3) 36.3 ± 3.0 
(3/27) (3/22) (3/21) (3/20) (3/20) (3/20) (3/20) (3/21) 
Gqfl G11- Cre- Tam+ 
123.0 








(8.7/33.6) 23.2 ± 3.5 
(3/22) (3/19) (3/19) (3/18) (3/18) (3/18) (3/18) (3/19) 
Gqwt G11wt Cre+ Tam- 
176.9 








(11.3/25.6) 16.5 ± 1.8 
(4/30) (4/23) (4/23) (4/22) (4/22) (4/22) (4/22) (4/21) 
Gqfl G11wt Cre- Tam+ 
170.9 








(9.9/64.4) 16.7 ± 2.0 
(4/32) (4/24) (4/23) (4/23) (4/23) (4/23) (4/23) (4/20) 
Gqfl G11wt Cre+ Tam+ 
183.8 








(21.1/85.8) 20.8 ± 3.5 
(3/22) (3/22) (3/19) (3/19) (3/19) (3/19) (3/19) (3/17) 
Gqwt G11wt Cre- Mig+ 
162.2 
(143.3/184.7) -72.6 ± 1.4 
117.2 
(92.1/125.6) 1.9 ± 0.3 3.9 ± 1 7.2 ± 1.7 27.6 ± 8.3 26.1 ± 4 
17/2 9/2 8/2 8/2 8/2 8/2 8/2 11/2 












(7.3/20.2) 25.5 ± 2.8 





Supplementary table 2: The electrophysiological results of hyperaldosteronism described in 3.2. In the first row of each genotype the 
results are shown either as median with corresponding 25/75 percentiles or as mean ± SEM. In the second row the first number shows 
the animal number and the second number shows the cell number. 
 
Genotype Cm VR AP amplitude TTP APD30 APD50 APD70 APD90 Itoc 
















(55.7/168.9) 20.3 ± 1.9 
41/4 36/4 16/4 29/4 15/4 15/4 15/4 15/4 29/4 

















(44.8/110.4) 30.4 ± 2.9 
55/6 54/6 16/6 36/6 15/6 15/6 15/6 15/6 36/6 

















(76.9/125.7) 21.4 ± 3 
38/4 41/4 15/4 22/4 22/4 22/4 22/4 22/4 22/4 

















(64.8/151.8) 25.7 ± 2.1 
57/4 50/4 13/4 28/4 28/4 28/4 28/4 28/4 28/4 
















(33.5/103.8) 42.8 ± 3.6 
33/3 22/3 18/3 24/3 24/3 24/3 24/3 24/3 24/3 

















(39.3/137.9) 33.6 ± 4.3 
24/4 23/4 15/4 16/4 14/4 14/4 14/4 14/4 16/4 
















(16.0/94) 46.5 ± 5.2 
38/3 20/3 14/3 15/3 14/3 14/3 14/3 14/3 15/3 

















(32.8/146.4) 28.4 ± 5.1 






Supplementary table 3: The results of ICa,L and gain measurements in I/E mice described in 3.3. In the first row of each parameter the 
results are shown either as mean ± SEM or as median with corresponding 25/75 percentiles at 0 mV test potential. In the second row the 
first number shows the animal number and the second number shows the cell number. 
 
 





185.1 ± 11.6 194.1 ± 12.0 
20/3 24/3 
Gain 
0.10 ± 0.02 0.43 ± 0.11 
18/3 19/3 
τ1 




































Supplementary table 4: The results of ICa,L and gain measurements in RacET mice described in 3.4. In the first 
row of each parameter the results are shown either as mean ± SEM or as median with corresponding 25/75 
percentiles at 0 mV test potential. In the second row the first number shows the animal number and the second 
number shows the cell number. 
 





0.08 ± 0.02 0.28 ± 0.1 
14/3 17/3 
τ1 






































Supplementary table 5: The electrophysiological results of application of 40 µM CytoD culture supplement 
described in 3.5. In the first row of each parameter the results are shown as mean ± SEM. In the second row the 
first number shows the animal number and the second number shows the cell number. 
 
Parameter DIV0 DIV0 DIV3 DIV3 
Cm 
137.9 ± 3.2 139.5 ± 9.6 102.2 ± 6.6 134.4 ± 8.2 
9/3 17/3 14/3 21/3 
VR 
-74.5 ± 0.8 -72.0 ± 0.8 -71.4 ± 0.6 -73.9 ± 0.5 
9/3 16/3 16/3 23/3 
AP amplitude 
99.6 ± 6.5 101.0 ± 4.9 91.3 ± 4.3 106.1 ± 2.5 
8/3 14/3 10/3 21/3 
APD30 
9.3 ± 2.3 8.6 ± 1.7 12.2 ± 4.6 22.3 ± 5.0 
8/3 12/3 12/3 9/3 
APD50 
11.2 ± 1.8 8.9 ± 1.2 12 ± 2.2 39.8 ± 9.4 
8/3 12/3 12/3 9/3 
APD70 
26.3 ± 6.4 20.7 ± 4.0 32.7 ± 10.5 103.4 ± 24.9 
8/3 12/3 12/3 9/3 
APD90 
33.4 ± 5.5 37.1 ± 5.7 40.6 ± 6.7 198.6 ± 51.1 

























Supplementary table 6: The electrophysiological results of application of 0.5 µM CytoD culture supplement 
described in 3.5. In the first row of each parameter the results are shown as mean ± SEM. In the second row the 
first number shows the animal number and the second number shows the cell number. 
 
Parameter DIV0 DIV0 DIV3 DIV3 
Cm 
202.8 ± 17.8 199.0 ± 14.5 117.2 ± 6.1 169.5 ± 11.7 
10/3 10/3 11/3 25/3 
VR 
-74.0 ± 0.6 -71.7 ± 0.9 -72.2 ± 1.0 -74.6 ± 0.6 
20/3 10/3 10/3 10/3 
AP amplitude 
103.1 ± 4.2 102.6 ± 4.1 80.2 ± 1.8 100.3 ± 3.5 
18/3 12/3 14/3 10/3 
APD30 
10.5 ± 1.8 9.6 ± 1.6 14.2 ± 4.6 11.0 ± 3.5 
13/3 14/3 7/3 7/3 
APD50 
20.4 ± 3.4 30.6 ± 8.8 18.4 ± 2.9 18.5 ± 5.3 
13/3 14/3 7/3 7/3 
APD70 
30.5 ± 4.9 27.8 ± 4.6 41.2 ± 12.7 26.1 ± 6.7 
13/3 14/3 7/3 7/3 
APD90 
61.8 ± 9.5 149.6 ± 28.2 47.9 ± 8.3 70.2 ± 18.3 
13/3 14/3 7/3 7/3 
 
